Cone-rod dystrophy 20

Mendelian MONDO:0014427 Pathograph 17 Show in embeddings browser Cone-rod dystrophy Inherited retinal dystrophy Ciliopathy

Cone-rod dystrophy 20 is a rare autosomal recessive inherited retinal dystrophy caused by biallelic variants in POC1B, which encodes POC1 centriolar protein B, a core centriole protein that localises to the basal body of the photoreceptor connecting cilium. The retinal disease is cone-predominant: most reported patients have a generalized or peripheral cone dystrophy with absent or reduced light-adapted electroretinogram responses and normal or near-normal rod responses, and a minority progress to cone-rod dystrophy. Onset is usually in childhood to early adulthood with reduced central vision, photophobia and impaired colour vision, but some patients have poor vision and nystagmus from early infancy, an achromatopsia-like presentation that later deteriorates. The course is slowly progressive. A distinctive clinical feature is that the fundus often looks normal, so diagnosis rests on electroretinography and on optical coherence tomography, which shows loss of the interdigitation zone and a blurred ellipsoid zone. The cone-dominated, normal-fundus presentation can mimic incomplete achromatopsia. One consanguineous family with a homozygous frameshift variant additionally had male infertility with oligoasthenoteratozoospermia, consistent with the role of centrioles in the sperm flagellum.

Ask OpenScientist

Ask a research question about Cone-rod dystrophy 20. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
4
Pathophys.
10
Phenotypes
17
Pathograph
1
Genes
1
Medical Actions
2
Models
8
References
1
Deep Research
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
Biallelic POC1B variants, homozygous in consanguineous families and compound heterozygous elsewhere. Reported alleles include missense, in-frame deletion, nonsense, frameshift, canonical, non-canonical and deep-intronic splice variants.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:25018096 SUPPORT Human Clinical
"in three siblings with autosomal-recessive cone dystrophy or cone-rod dystrophy and compound-heterozygous POC1B mutations"
Homozygous and compound heterozygous POC1B variants in two families with autosomal recessive cone or cone-rod dystrophy.
PMID:24945461 SUPPORT Human Clinical
"The disease gene mapped to a less than 2-megabase recessive locus at 12q21.33 with a logarithm of odds score of 3.92. At the locus, we identified a homozygous missense POC1B p.R106P mutation"
Independent linkage to a recessive locus in a consanguineous family, with a homozygous POC1B variant at the locus.
⚙

Pathophysiology

4
Biallelic POC1B Loss-of-Function Variants
Biallelic POC1B variants. Missense and in-frame alleles such as p.Arg106Pro and p.Gln67del lost basal-body localization in overexpressed RPE1 cells and lost the interaction with FAM161A, although p.Arg106Pro localized normally to the centrosome in a separate HEK293T assay, so the localization defect is assay-dependent; nonsense, frameshift and splice alleles, including a deep-intronic variant that activates a pseudoexon, are predicted to remove the protein.
POC1B hgnc:30836 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves POC1B (hgnc:30836). hgnc:30836 is a gene from the HUGO Gene Nomenclature Committee.
POC1A-POC1B heterodimerization GO:0046982 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased POC1A-POC1B heterodimerization, annotated with protein heterodimerization activity (GO:0046982). GO:0046982 is a molecular function from the Gene Ontology.
Show evidence (5 references)
PMID:39543170 SUPPORT In Vitro
"We demonstrate the importance of an interaction network organised by POC1A-POC1B heterodimers within the centriole lumen, where the WD40 domain of POC1B localises close to the centriole wall, while the POC5-interacting WD40 of POC1A resides in the centriole lumen."
POC1B acts as one half of the POC1A-POC1B heterodimer that organises the inner-scaffold interaction network; this is the molecular activity lost when POC1B is absent or mislocalised.
PMID:39543170 SUPPORT In Vitro
"Disruption of POC1A or POC1B leads to centriole microtubule defects and deletion of both genes causes centriole disintegration."
Loss of POC1B alone is sufficient to damage centriole microtubules.
PMID:25018096 SUPPORT In Vitro
"Upon overexpression of POC1B in human TERT-immortalized retinal pigment epithelium 1 cells, the encoded wild-type protein localized to the basal body of the primary cilium, whereas this localization was lost for p.Arg106Pro and p.Gln67del variant forms of POC1B."
Patient missense and in-frame alleles lose basal-body localization.
+ 2 more references
Photoreceptor Basal Body and Connecting Cilium Defect
POC1B is a centriolar WD40-repeat protein that, together with POC1A, maintains centriole integrity. In photoreceptors it localizes to the basal body and centriole adjacent to the connecting cilium, the specialized primary cilium through which outer-segment proteins are transported. Loss of POC1B function disrupts this sensory cilium; in zebrafish knockdown the connecting cilia are shortened and reduced and the outer segments are shortened.
retinal cone cell CL:0000573 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves retinal cone cell (CL:0000573). CL:0000573 is a cell type from the Cell Ontology. retinal rod cell CL:0000604 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves retinal rod cell (CL:0000604). CL:0000604 is a cell type from the Cell Ontology.
cilium assembly GO:0060271 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased cilium assembly (GO:0060271). GO:0060271 is a biological process from the Gene Ontology.
ciliary basal body GO:0036064 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves ciliary basal body (GO:0036064). GO:0036064 is a cellular component from the Gene Ontology. photoreceptor connecting cilium GO:0032391 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves photoreceptor connecting cilium (GO:0032391). GO:0032391 is a cellular component from the Gene Ontology.
Show evidence (3 references)
PMID:25044745 SUPPORT In Vitro
"In human and mouse retina, POC1B localized to the basal body and centriole adjacent to the connecting cilium of photoreceptors and in synapses of the outer plexiform layer."
Places POC1B at the photoreceptor basal body. Graded IN_VITRO because the localization comes from immunostaining of human and mouse retinal tissue sections, which is ex vivo, not an in vivo model experiment. The same paper's attribution of a Joubert syndrome phenotype to POC1B was later withdrawn (see notes); this localization finding is independent of that claim.
PMID:23015594 SUPPORT In Vitro
"Hence, Poc1A and Poc1B play redundant, but essential, roles in generation of stable centrioles, but Poc1B may have additional independent functions during cell cycle progression."
Establishes the centriole-integrity function of POC1B that underlies the basal-body defect.
PMID:26188096 SUPPORT Model Organism
"These data suggest that poc1b is required for normal development and ciliogenesis of retinal photoreceptor sensory cilia and other cilia."
Knockdown evidence that POC1B is required for photoreceptor sensory cilium formation.
Progressive Cone-Predominant Photoreceptor Degeneration
Photoreceptor degeneration affecting cones first and most. Most patients have generalized or peripheral cone dystrophy with normal dark-adapted responses; rod responses become subnormal in some patients and a minority progress to frank cone-rod dystrophy. Structurally the outer retina shows loss of the interdigitation zone (cone outer segment tips) and a blurred ellipsoid zone, often with a normal-appearing fundus. Severity ranges from early-childhood onset to a late-onset mild form with relatively preserved cone function.
retinal cone cell CL:0000573 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves retinal cone cell (CL:0000573). CL:0000573 is a cell type from the Cell Ontology.
retina UBERON:0000966 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in retina (UBERON:0000966). UBERON:0000966 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (3 references)
PMID:31390656 SUPPORT Human Clinical
"Generalized or peripheral cone dystrophy with normal funduscopic appearance is the representative phenotype of POC1B-associated retinopathy in our cohort."
The cone-predominant pattern across a seven-family cohort.
PMID:33657974 SUPPORT Human Clinical
"Follow-up three years later showed progression to a cone-rod dystrophy."
Documents progression from cone dystrophy to cone-rod dystrophy.
PMID:37227616 SUPPORT Human Clinical
"We reported the case of an older patient with POC1B-associated retinopathy, demonstrating late-onset visual decrease, good visual acuity, and relatively preserved cone system function."
The mild end of the severity range.
Sperm Centriole and Flagellum Defect
In the one family reported with both cone-rod dystrophy and oligoasthenoteratozoospermia, POC1B protein was absent from sperm, and mice knocked in for the same frameshift allele showed abnormal acrosome and flagellum formation.
sperm CL:0000019 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves sperm (CL:0000019). CL:0000019 is a cell type from the Cell Ontology.
sperm flagellum assembly GO:0120316 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased sperm flagellum assembly (GO:0120316). GO:0120316 is a biological process from the Gene Ontology. acrosome assembly GO:0001675 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased acrosome assembly (GO:0001675). GO:0001675 is a biological process from the Gene Ontology.
testis UBERON:0000473 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in testis (UBERON:0000473). UBERON:0000473 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:37070736 SUPPORT Model Organism
"Additionally, testicular histology and transmission electron microscopy analysis of the testes and sperm indicated that Poc1b mutation results in abnormal formation of acrosomes and flagella."
Knock-in mice carrying the patient allele show defective acrosome and flagellum formation.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Cone-rod dystrophy 20 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

10
Eye 9
Cone/cone-rod dystrophy HP:0000548 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cone/cone-rod dystrophy (HP:0000548), qualified as course progressive. HP:0000548 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (2 references)
PMID:24945461 SUPPORT Human Clinical
"POC1B is a novel gene for a new disease typical of CORD except that patients did not report night blindness. The clinical course was slowly progressive."
Cone-rod dystrophy with a slowly progressive course and without reported night blindness.
PMID:34065499 SUPPORT Human Clinical
"All patients displayed a similar, slowly progressive retinopathy (cone dystrophy or cone-rod dystrophy) with normal funduscopy but disrupted outer retinal layers on optical coherence tomography and variable age of onset."
Cone or cone-rod dystrophy with normal fundus in an independent series.
Undetectable light-adapted electroretinogram VERY_FREQUENT HP:0030465 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Undetectable light-adapted electroretinogram (HP:0030465). HP:0030465 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:24945461 SUPPORT Human Clinical
"Cone response was nonrecordable in all patients, whereas rod response was nonrecordable in the eldest patient and subnormal in the others."
Non-recordable cone responses in every affected family member.
PMID:37246743 SUPPORT Human Clinical
"Full-field electroretinography demonstrated undetectable light-adapted responses and normal dark-adapted responses in all patients."
Undetectable light-adapted with preserved dark-adapted responses in two further families.
PMID:31390656 SUPPORT Human Clinical
"The full-field photopic ERGs were reduced or extinguished with normal scotopic responses."
Reduced or extinguished photopic responses across the eight patients of the seven-family cohort; the phenotype is bound to the undetectable form, which is the commonest, and some patients have reduced rather than absent responses.
Photoreceptor outer segment loss on macular OCT VERY_FREQUENT HP:0030610 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Photoreceptor outer segment loss on macular OCT (HP:0030610). HP:0030610 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:31390656 SUPPORT Human Clinical
"Optical coherence tomography revealed an absence of the interdigitation zone and blurred ellipsoid zone in the posterior pole, but the foveal structures were preserved in three cases."
Loss of the cone outer segment tip line on OCT.
PMID:24945461 SUPPORT Human Clinical
"In all patients, a disrupted inner segment/outer segment line and the external limiting membrane were noted as a single blurry line at the central fovea, and the cone outer segment tip line was absent."
Absent cone outer segment tip line in every patient of the original family.
Reduced visual acuity HP:0007663 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Reduced visual acuity (HP:0007663). HP:0007663 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:29220607 SUPPORT Human Clinical
"The patient was a 20-year-old Japanese man whose chief complaint was a progressive decrease in his central vision."
Progressive loss of central vision as the presenting symptom.
PMID:37246743 SUPPORT Human Clinical
"Ophthalmic examination showed decreased Snellen visual acuities (range: 20/100-20/300) and color vision bilaterally."
Reduced visual acuity in three affected men.
Photophobia HP:0000613 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Photophobia (HP:0000613). HP:0000613 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:24945461 SUPPORT Human Clinical
"The clinical phenotype was typical CORD with photophobia, decreased central vision, and dyschromatopsia."
Photophobia reported in the original family.
PMID:34065499 SUPPORT Human Clinical
"Other symptoms were decreased visual acuity and photophobia."
Photophobia in an independent series.
Dyschromatopsia HP:0007641 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dyschromatopsia (HP:0007641). HP:0007641 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:24945461 SUPPORT Human Clinical
"The clinical phenotype was typical CORD with photophobia, decreased central vision, and dyschromatopsia."
Impaired colour vision in the original family.
PMID:39568138 SUPPORT Human Clinical
"The proband, a 63-years old male, showed severely reduced day vision, a visual acuity of counting fingers (CF), color vision deficiency, high myopia and photophobia."
Colour vision deficiency in a further family.
Central scotoma HP:0000603 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Central scotoma (HP:0000603). HP:0000603 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:39568138 SUPPORT Human Clinical
"Full visual field tests showed bilateral central scotoma, while single visual field tests indicated bilateral generalized depression of the visual field."
Bilateral central scotoma on perimetry.
PMID:25018096 SUPPORT Human Clinical
"relative central scotoma, mild peripheral constriction (13 years)"
Goldmann perimetry row of the clinical table; all four patients in the gene-discovery report had a relative or absolute central scotoma.
Nystagmus HP:0000639 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Nystagmus (HP:0000639), qualified as infantile onset. HP:0000639 is a phenotype from the Human Phenotype Ontology.
Onset: INFANTILE
Show evidence (3 references)
PMID:25018096 SUPPORT Human Clinical
"in another sibling and in one isolated individual, poor visual acuity and nystagmus were present from early infancy, suggesting a form of ACHM."
Nystagmus from early infancy in two of four affected individuals, which supports the infantile onset recorded here.
PMID:25018096 SUPPORT Human Clinical
"The proband (A-II:1) of family A presented with reduced visual acuity in early infancy and mild nystagmus."
Individual-level report of early-infancy nystagmus.
PMID:34065499 SUPPORT Human Clinical
"All patients showed impaired cone function leading to reduced visual acuity, color vision disturbances, photophobia or nystagmus."
Nystagmus among the cone-dysfunction symptoms in an independent series.
High myopia HP:0011003 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is High myopia (HP:0011003). HP:0011003 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:39568138 SUPPORT Human Clinical
"The proband, a 63-years old male, showed severely reduced day vision, a visual acuity of counting fingers (CF), color vision deficiency, high myopia and photophobia."
High myopia in a homozygous POC1B patient.
PMID:41293231 SUPPORT Human Clinical
"Cycloplegic refraction showed high myopia (4 diopters and 8 diopters for the right and left eyes, respectively) with mild astigmatism."
High myopia in an affected child of a second family with a homozygous POC1B frameshift.
Genitourinary 1
Male infertility HP:0003251 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Male infertility (HP:0003251). HP:0003251 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37070736 SUPPORT Human Clinical
"Here, whole-exome sequencing was performed to identify a homozygous frameshift variant (c.151delG) in POC1B in the two brothers who had been diagnosed with both CORD and OAT from a consanguineous family."
Two brothers with both cone-rod dystrophy and oligoasthenoteratozoospermia.
🧬

Genetic Associations

1
POC1B (Causal biallelic variant)
Gene: POC1B hgnc:30836 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is POC1B (hgnc:30836). hgnc:30836 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (2 references)
PMID:25018096 SUPPORT Human Clinical
"in POC1B, encoding POC1 centriolar protein B, in three siblings with autosomal-recessive cone dystrophy or cone-rod dystrophy"
Identification of POC1B as the causal gene.
PMID:40170356 SUPPORT Human Clinical
"EOSRD and PKD can fully be ascribed to this CEP290 variant, whose effect outshines the "background" non-syndromic POC1B retinopathy and co-segregates with the severe syndromic phenotype. Our novel findings in this family no longer justify POC1B as a JBTS gene."
Withdraws the earlier attribution of Joubert syndrome to POC1B and restricts the POC1B phenotype to non-syndromic retinopathy.
💊

Medical Actions

1
Low-vision support and photophobia management
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Platform: Device
No disease-modifying treatment exists. Management is supportive: low-vision aids, tinted or filtered lenses for photophobia, and periodic ophthalmological follow-up. Genetic testing is what separates the disorder from incomplete achromatopsia, which it resembles.
Target Phenotypes: Reduced visual acuity HP:0007663 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Reduced visual acuity (HP:0007663). HP:0007663 is a phenotype from the Human Phenotype Ontology. Photophobia HP:0000613 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Photophobia (HP:0000613). HP:0000613 is a phenotype from the Human Phenotype Ontology.
📊

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
No population estimate exists. POC1B accounted for 7 of 548 families in the Japan Eye Genetics Consortium inherited retinal disease database, which is a diagnostic-yield figure in a referral cohort and not a population rate.
Show evidence (2 references)
PMID:31390656 SUPPORT Human Clinical
"Whole-exome sequencing with targeted analyses identified homozygous or compound heterozygous mutations of the POC1B gene in 7 of 548 families in the JEGC database."
The share of a national retinal-dystrophy cohort explained by POC1B, showing the disorder is rare.
PMID:34065499 SUPPORT Human Clinical
"Mutations in POC1B are a rare cause of inherited retinal degeneration."
States that the disorder is a rare cause of inherited retinal disease.
🐁

Animal Models

2
Zebrafish poc1b morphant
Morpholino knockdown of poc1b produces small eyes, impaired optokinetic responses and shortened photoreceptor outer segments, partially rescued by wild-type but not patient-allele human POC1B mRNA.
Species
Zebrafish
Genotype
poc1b translation-blocking morpholino knockdown
Publication
Poc1b c.151delG knock-in mouse
CRISPR knock-in of the frameshift allele found in two brothers with cone-rod dystrophy and oligoasthenoteratozoospermia.
Species
Mouse
Genotype
Poc1b c.151delG homozygous knock-in
Publication
{ }

Source YAML

click to show
name: Cone-rod dystrophy 20
creation_date: "2026-10-08T00:00:00Z"
category: Mendelian
synonyms:
- CORD20
- POC1B cone-rod dystrophy
- POC1B-associated retinopathy
- cone-rod dystrophy caused by mutation in POC1B
- cone-rod dystrophy type 20
description: >-
  Cone-rod dystrophy 20 is a rare autosomal recessive inherited retinal
  dystrophy caused by biallelic variants in POC1B, which encodes POC1
  centriolar protein B, a core centriole protein that localises to the basal
  body of the photoreceptor connecting cilium. The retinal disease is
  cone-predominant: most reported patients have a generalized or peripheral
  cone dystrophy with absent or reduced light-adapted electroretinogram
  responses and normal or near-normal rod responses, and a minority progress to
  cone-rod dystrophy. Onset is usually in childhood to early adulthood with
  reduced central vision, photophobia and impaired colour vision, but some
  patients have poor vision and nystagmus from early infancy, an
  achromatopsia-like presentation that later deteriorates. The course is
  slowly progressive. A distinctive clinical feature is that the
  fundus often looks normal, so diagnosis rests on electroretinography and on
  optical coherence tomography, which shows loss of the interdigitation zone and
  a blurred ellipsoid zone. The cone-dominated, normal-fundus presentation can
  mimic incomplete achromatopsia. One consanguineous family with a homozygous
  frameshift variant additionally had male infertility with
  oligoasthenoteratozoospermia, consistent with the role of centrioles in the
  sperm flagellum.
disease_term:
  preferred_term: cone-rod dystrophy 20
  term:
    id: MONDO:0014427
    label: cone-rod dystrophy 20
parents:
- Cone-rod dystrophy
- Inherited retinal dystrophy
- Ciliopathy
references:
- reference: PMID:25018096
  title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
- reference: PMID:24945461
  title: Novel recessive cone-rod dystrophy caused by POC1B mutation.
- reference: PMID:31390656
  title: "Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic Appearance."
- reference: PMID:34065499
  title: Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants.
- reference: PMID:25044745
  title: Mutation of POC1B in a severe syndromic retinal ciliopathy.
- reference: PMID:40170356
  title: Severe Joubert syndrome in family with homozygous POC1B p.Arg106Pro variant is due to a co-inherited deep-intronic mutation in the neighboring CEP290 gene.
- reference: PMID:37070736
  title: Homozygous frameshift variant in POC1B causes male infertility with oligoasthenoteratozoospermia in human and mice.
- reference: PMID:39543170
  title: An interaction network of inner centriole proteins organised by POC1A-POC1B heterodimer crosslinks ensures centriolar integrity.
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Biallelic POC1B variants, homozygous in consanguineous families and
    compound heterozygous elsewhere. Reported alleles include missense,
    in-frame deletion, nonsense, frameshift, canonical, non-canonical and
    deep-intronic splice variants.
  evidence:
  - reference: PMID:25018096
    reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      in three siblings with autosomal-recessive cone dystrophy or cone-rod dystrophy and compound-heterozygous POC1B mutations
    explanation: >-
      Homozygous and compound heterozygous POC1B variants in two families with
      autosomal recessive cone or cone-rod dystrophy.
  - reference: PMID:24945461
    reference_title: Novel recessive cone-rod dystrophy caused by POC1B mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The disease gene mapped to a less than 2-megabase recessive locus at 12q21.33 with a logarithm of odds score of 3.92. At the locus, we identified a homozygous missense POC1B p.R106P mutation
    explanation: >-
      Independent linkage to a recessive locus in a consanguineous family,
      with a homozygous POC1B variant at the locus.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    No population estimate exists. POC1B accounted for 7 of 548 families in the
    Japan Eye Genetics Consortium inherited retinal disease database, which is a
    diagnostic-yield figure in a referral cohort and not a population rate.
  evidence:
  - reference: PMID:31390656
    reference_title: "Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic Appearance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Whole-exome sequencing with targeted analyses identified homozygous or compound heterozygous mutations of the POC1B gene in 7 of 548 families in the JEGC database.
    explanation: >-
      The share of a national retinal-dystrophy cohort explained by POC1B,
      showing the disorder is rare.
  - reference: PMID:34065499
    reference_title: Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Mutations in POC1B are a rare cause of inherited retinal degeneration.
    explanation: >-
      States that the disorder is a rare cause of inherited retinal disease.
pathophysiology:
- name: Biallelic POC1B Loss-of-Function Variants
  biological_scale: MOLECULAR
  description: >-
    Biallelic POC1B variants. Missense and in-frame alleles such as p.Arg106Pro
    and p.Gln67del lost basal-body localization in overexpressed RPE1 cells and
    lost the interaction with FAM161A, although p.Arg106Pro localized normally to
    the centrosome in a separate HEK293T assay, so the localization defect is
    assay-dependent; nonsense, frameshift and splice alleles,
    including a deep-intronic variant that activates a pseudoexon, are
    predicted to remove the protein.
  genes:
  - preferred_term: POC1B
    term:
      id: hgnc:30836
      label: POC1B
  molecular_functions:
  - preferred_term: POC1A-POC1B heterodimerization
    modifier: DECREASED
    term:
      id: GO:0046982
      label: protein heterodimerization activity
  evidence:
  - reference: PMID:39543170
    reference_title: An interaction network of inner centriole proteins organised by POC1A-POC1B heterodimer crosslinks ensures centriolar integrity.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We demonstrate the importance of an interaction network organised by POC1A-POC1B heterodimers within the centriole lumen, where the WD40 domain of POC1B localises close to the centriole wall, while the POC5-interacting WD40 of POC1A resides in the centriole lumen.
    explanation: >-
      POC1B acts as one half of the POC1A-POC1B heterodimer that organises the
      inner-scaffold interaction network; this is the molecular activity lost
      when POC1B is absent or mislocalised.
  - reference: PMID:39543170
    reference_title: An interaction network of inner centriole proteins organised by POC1A-POC1B heterodimer crosslinks ensures centriolar integrity.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Disruption of POC1A or POC1B leads to centriole microtubule defects and deletion of both genes causes centriole disintegration.
    explanation: >-
      Loss of POC1B alone is sufficient to damage centriole microtubules.
  - reference: PMID:25018096
    reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Upon overexpression of POC1B in human TERT-immortalized retinal pigment epithelium 1 cells, the encoded wild-type protein localized to the basal body of the primary cilium, whereas this localization was lost for p.Arg106Pro and p.Gln67del variant forms of POC1B.
    explanation: >-
      Patient missense and in-frame alleles lose basal-body localization.
  - reference: PMID:25044745
    reference_title: Mutation of POC1B in a severe syndromic retinal ciliopathy.
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: >-
      In HEK293T cells transfected with a plasmid containing the p.Arg106Pro mutation, the protein localized normally at the centrosome
    explanation: >-
      Contradicts the localization part of the claim for p.Arg106Pro in a
      different cell system; the FAM161A-binding defect is not addressed here.
  - reference: PMID:34065499
    reference_title: Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Splicing analysis revealed that the non-canonical splice site variant c.561-3T>C leads to exon skipping while the novel deep intronic variant c.1033-327T>A causes pseudoexon activation.
    explanation: >-
      Splice-assay demonstration that intronic patient alleles disrupt the
      POC1B transcript.
  downstream:
  - target: Photoreceptor Basal Body and Connecting Cilium Defect
    description: >-
      POC1B normally sits at the basal body adjacent to the photoreceptor
      connecting cilium and binds FAM161A there; the patient alleles lose both
      the localization and the interaction.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:25018096
      reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        This was confirmed in coimmunoprecipitation and colocalization assays, which both showed loss of FAM161A interaction with p.Arg106Pro and p.Gln67del variant forms of POC1B.
      explanation: >-
        Patient alleles lose the interaction with FAM161A, a ciliopathy protein
        at the base of the photoreceptor connecting cilium.
  - target: Sperm Centriole and Flagellum Defect
    description: >-
      A separate branch of the same lesion in the male germline, reported in
      one family carrying a homozygous frameshift allele.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:37070736
      reference_title: Homozygous frameshift variant in POC1B causes male infertility with oligoasthenoteratozoospermia in human and mice.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Transcript and protein analyses of biological samples from the two patients carrying the variant showed that POC1B protein is lost in sperm cells.
      explanation: >-
        The frameshift allele removes POC1B from patient sperm.
- name: Photoreceptor Basal Body and Connecting Cilium Defect
  biological_scale: CELLULAR
  description: >-
    POC1B is a centriolar WD40-repeat protein that, together with POC1A,
    maintains centriole integrity. In photoreceptors it localizes to the basal
    body and centriole adjacent to the connecting cilium, the specialized
    primary cilium through which outer-segment proteins are transported. Loss of
    POC1B function disrupts this sensory cilium; in zebrafish knockdown the
    connecting cilia are shortened and reduced and the outer segments are
    shortened.
  cellular_components:
  - preferred_term: ciliary basal body
    term:
      id: GO:0036064
      label: ciliary basal body
  - preferred_term: photoreceptor connecting cilium
    term:
      id: GO:0032391
      label: photoreceptor connecting cilium
  biological_processes:
  - preferred_term: cilium assembly
    modifier: DECREASED
    term:
      id: GO:0060271
      label: cilium assembly
  cell_types:
  - preferred_term: retinal cone cell
    term:
      id: CL:0000573
      label: retinal cone cell
  - preferred_term: retinal rod cell
    term:
      id: CL:0000604
      label: retinal rod cell
  evidence:
  - reference: PMID:25044745
    reference_title: Mutation of POC1B in a severe syndromic retinal ciliopathy.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In human and mouse retina, POC1B localized to the basal body and centriole adjacent to the connecting cilium of photoreceptors and in synapses of the outer plexiform layer.
    explanation: >-
      Places POC1B at the photoreceptor basal body. Graded IN_VITRO because the
      localization comes from immunostaining of human and mouse retinal tissue
      sections, which is ex vivo, not an in vivo model experiment. The same paper's
      attribution of a Joubert syndrome phenotype to POC1B was later withdrawn
      (see notes); this localization finding is independent of that claim.
  - reference: PMID:23015594
    reference_title: Poc1A and Poc1B act together in human cells to ensure centriole integrity.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Hence, Poc1A and Poc1B play redundant, but essential, roles in generation of stable centrioles, but Poc1B may have additional independent functions during cell cycle progression.
    explanation: >-
      Establishes the centriole-integrity function of POC1B that underlies the
      basal-body defect.
  - reference: PMID:26188096
    reference_title: Knockdown of poc1b causes abnormal photoreceptor sensory cilium and vision impairment in zebrafish.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      These data suggest that poc1b is required for normal development and ciliogenesis of retinal photoreceptor sensory cilia and other cilia.
    explanation: >-
      Knockdown evidence that POC1B is required for photoreceptor sensory cilium
      formation.
  downstream:
  - target: Progressive Cone-Predominant Photoreceptor Degeneration
    description: >-
      A defective photoreceptor sensory cilium leads to shortened outer
      segments and photoreceptor dysfunction.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:25018096
      reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Morpholino-oligonucleotide-induced knockdown of poc1b translation in zebrafish resulted in a dose-dependent small-eye phenotype, impaired optokinetic responses, and decreased length of photoreceptor outer segments.
      explanation: >-
        Loss of poc1b in zebrafish shortens photoreceptor outer segments and
        impairs visual responses; indirect because it is a morpholino
        knockdown in a non-human model.
    - reference: PMID:25018096
      reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
      supports: SUPPORT
      quote_role: PRIMARY_RESULT
      evidence_source: OTHER
      snippet: >-
        Altogether, this study demonstrates that POC1B mutations result in a defect of the photoreceptor sensory cilium and thus affect cone and rod photoreceptors.
      explanation: >-
        The authors' synthesis of the human genetic, cell and zebrafish data
        linking the ciliary defect to photoreceptor disease.
- name: Progressive Cone-Predominant Photoreceptor Degeneration
  biological_scale: TISSUE
  description: >-
    Photoreceptor degeneration affecting cones first and most. Most patients
    have generalized or peripheral cone dystrophy with normal dark-adapted
    responses; rod responses become subnormal in some patients and a minority
    progress to frank cone-rod dystrophy. Structurally the outer retina shows
    loss of the interdigitation zone (cone outer segment tips) and a blurred
    ellipsoid zone, often with a normal-appearing fundus. Severity ranges from
    early-childhood onset to a late-onset mild form with relatively preserved
    cone function.
  cell_types:
  - preferred_term: retinal cone cell
    term:
      id: CL:0000573
      label: retinal cone cell
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  evidence:
  - reference: PMID:31390656
    reference_title: "Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic Appearance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Generalized or peripheral cone dystrophy with normal funduscopic appearance is the representative phenotype of POC1B-associated retinopathy in our cohort.
    explanation: >-
      The cone-predominant pattern across a seven-family cohort.
  - reference: PMID:33657974
    reference_title: A homozygous POC1B variant causes recessive cone-rod dystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Follow-up three years later showed progression to a cone-rod dystrophy.
    explanation: >-
      Documents progression from cone dystrophy to cone-rod dystrophy.
  - reference: PMID:37227616
    reference_title: A mild form of POC1B-associated retinal dystrophy with relatively preserved cone system function.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We reported the case of an older patient with POC1B-associated retinopathy, demonstrating late-onset visual decrease, good visual acuity, and relatively preserved cone system function.
    explanation: >-
      The mild end of the severity range.
  downstream:
  - target: Cone/cone-rod dystrophy
    causal_link_type: DIRECT
  - target: Undetectable light-adapted electroretinogram
    causal_link_type: DIRECT
  - target: Photoreceptor outer segment loss on macular OCT
    causal_link_type: DIRECT
  - target: Reduced visual acuity
    causal_link_type: DIRECT
  - target: Photophobia
    causal_link_type: DIRECT
  - target: Dyschromatopsia
    causal_link_type: DIRECT
  - target: Central scotoma
    causal_link_type: DIRECT
  - target: Nystagmus
    causal_link_type: DIRECT
- name: Sperm Centriole and Flagellum Defect
  biological_scale: CELLULAR
  description: >-
    In the one family reported with both cone-rod dystrophy and
    oligoasthenoteratozoospermia, POC1B protein was absent from sperm, and mice
    knocked in for the same frameshift allele showed abnormal acrosome and
    flagellum formation.
  cell_types:
  - preferred_term: sperm
    term:
      id: CL:0000019
      label: sperm
  biological_processes:
  - preferred_term: sperm flagellum assembly
    modifier: DECREASED
    term:
      id: GO:0120316
      label: sperm flagellum assembly
  - preferred_term: acrosome assembly
    modifier: DECREASED
    term:
      id: GO:0001675
      label: acrosome assembly
  locations:
  - preferred_term: testis
    term:
      id: UBERON:0000473
      label: testis
  evidence:
  - reference: PMID:37070736
    reference_title: Homozygous frameshift variant in POC1B causes male infertility with oligoasthenoteratozoospermia in human and mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Additionally, testicular histology and transmission electron microscopy analysis of the testes and sperm indicated that Poc1b mutation results in abnormal formation of acrosomes and flagella.
    explanation: >-
      Knock-in mice carrying the patient allele show defective acrosome and
      flagellum formation.
  downstream:
  - target: Male infertility
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:37070736
      reference_title: Homozygous frameshift variant in POC1B causes male infertility with oligoasthenoteratozoospermia in human and mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Notably, poc1bc.151delG/c.151delG KI male mice presented with OAT phenotype.
      explanation: >-
        The patient allele reproduces oligoasthenoteratozoospermia in mice.
phenotypes:
- name: Cone/cone-rod dystrophy
  category: Ophthalmologic
  diagnostic: true
  description: >-
    Cone dystrophy or cone-rod dystrophy, usually with onset in childhood to
    early adulthood and a slowly progressive course. Night blindness was not
    reported in the original consanguineous family.
  phenotype_term:
    preferred_term: Cone/cone-rod dystrophy
    term:
      id: HP:0000548
      label: Cone/cone-rod dystrophy
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:24945461
    reference_title: Novel recessive cone-rod dystrophy caused by POC1B mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      POC1B is a novel gene for a new disease typical of CORD except that patients did not report night blindness. The clinical course was slowly progressive.
    explanation: >-
      Cone-rod dystrophy with a slowly progressive course and without
      reported night blindness.
  - reference: PMID:34065499
    reference_title: Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients displayed a similar, slowly progressive retinopathy (cone dystrophy or cone-rod dystrophy) with normal funduscopy but disrupted outer retinal layers on optical coherence tomography and variable age of onset.
    explanation: >-
      Cone or cone-rod dystrophy with normal fundus in an independent series.
- name: Undetectable light-adapted electroretinogram
  category: Ophthalmologic
  diagnostic: true
  description: >-
    Full-field photopic responses are reduced to non-recordable while scotopic
    responses are normal or subnormal, the electrophysiological signature of a
    cone-predominant dystrophy.
  phenotype_term:
    preferred_term: Undetectable light-adapted electroretinogram
    term:
      id: HP:0030465
      label: Undetectable light-adapted electroretinogram
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:24945461
    reference_title: Novel recessive cone-rod dystrophy caused by POC1B mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Cone response was nonrecordable in all patients, whereas rod response was nonrecordable in the eldest patient and subnormal in the others.
    explanation: >-
      Non-recordable cone responses in every affected family member.
  - reference: PMID:37246743
    reference_title: Phenotypic and genotypic features of POC1B-associated cone dystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Full-field electroretinography demonstrated undetectable light-adapted responses and normal dark-adapted responses in all patients.
    explanation: >-
      Undetectable light-adapted with preserved dark-adapted responses in two
      further families.
  - reference: PMID:31390656
    reference_title: "Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic Appearance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The full-field photopic ERGs were reduced or extinguished with normal scotopic responses.
    explanation: >-
      Reduced or extinguished photopic responses across the eight patients of
      the seven-family cohort; the phenotype is bound to the undetectable form,
      which is the commonest, and some patients have reduced rather than absent
      responses.
- name: Photoreceptor outer segment loss on macular OCT
  category: Ophthalmologic
  description: >-
    Optical coherence tomography shows absence of the interdigitation zone
    (cone outer segment tip line) and a blurred ellipsoid zone, often with a
    normal fundus on ophthalmoscopy.
  phenotype_term:
    preferred_term: Photoreceptor outer segment loss on macular OCT
    term:
      id: HP:0030610
      label: Photoreceptor outer segment loss on macular OCT
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:31390656
    reference_title: "Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic Appearance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Optical coherence tomography revealed an absence of the interdigitation zone and blurred ellipsoid zone in the posterior pole, but the foveal structures were preserved in three cases.
    explanation: >-
      Loss of the cone outer segment tip line on OCT.
  - reference: PMID:24945461
    reference_title: Novel recessive cone-rod dystrophy caused by POC1B mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In all patients, a disrupted inner segment/outer segment line and the external limiting membrane were noted as a single blurry line at the central fovea, and the cone outer segment tip line was absent.
    explanation: >-
      Absent cone outer segment tip line in every patient of the original
      family.
- name: Reduced visual acuity
  category: Ophthalmologic
  description: >-
    Decreased central vision, the usual presenting complaint.
  phenotype_term:
    preferred_term: Reduced visual acuity
    term:
      id: HP:0007663
      label: Reduced visual acuity
  evidence:
  - reference: PMID:29220607
    reference_title: Case of cone dystrophy with normal fundus appearance associated with biallelic POC1B variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient was a 20-year-old Japanese man whose chief complaint was a progressive decrease in his central vision.
    explanation: >-
      Progressive loss of central vision as the presenting symptom.
  - reference: PMID:37246743
    reference_title: Phenotypic and genotypic features of POC1B-associated cone dystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Ophthalmic examination showed decreased Snellen visual acuities (range: 20/100-20/300) and color vision bilaterally.
    explanation: >-
      Reduced visual acuity in three affected men.
- name: Photophobia
  category: Ophthalmologic
  phenotype_term:
    preferred_term: Photophobia
    term:
      id: HP:0000613
      label: Photophobia
  evidence:
  - reference: PMID:24945461
    reference_title: Novel recessive cone-rod dystrophy caused by POC1B mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The clinical phenotype was typical CORD with photophobia, decreased central vision, and dyschromatopsia.
    explanation: >-
      Photophobia reported in the original family.
  - reference: PMID:34065499
    reference_title: Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other symptoms were decreased visual acuity and photophobia.
    explanation: >-
      Photophobia in an independent series.
- name: Dyschromatopsia
  category: Ophthalmologic
  phenotype_term:
    preferred_term: Dyschromatopsia
    term:
      id: HP:0007641
      label: Dyschromatopsia
  evidence:
  - reference: PMID:24945461
    reference_title: Novel recessive cone-rod dystrophy caused by POC1B mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The clinical phenotype was typical CORD with photophobia, decreased central vision, and dyschromatopsia.
    explanation: >-
      Impaired colour vision in the original family.
  - reference: PMID:39568138
    reference_title: A novel homozygous missense variant in POC1B causes cone dystrophy in a consanguineous Pakistani family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The proband, a 63-years old male, showed severely reduced day vision, a visual acuity of counting fingers (CF), color vision deficiency, high myopia and photophobia.
    explanation: >-
      Colour vision deficiency in a further family.
- name: Central scotoma
  category: Ophthalmologic
  phenotype_term:
    preferred_term: Central scotoma
    term:
      id: HP:0000603
      label: Central scotoma
  evidence:
  - reference: PMID:39568138
    reference_title: A novel homozygous missense variant in POC1B causes cone dystrophy in a consanguineous Pakistani family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Full visual field tests showed bilateral central scotoma, while single visual field tests indicated bilateral generalized depression of the visual field.
    explanation: >-
      Bilateral central scotoma on perimetry.
  - reference: PMID:25018096
    reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      relative central scotoma, mild peripheral constriction (13 years)
    explanation: >-
      Goldmann perimetry row of the clinical table; all four patients in the
      gene-discovery report had a relative or absolute central scotoma.
- name: Nystagmus
  category: Ophthalmologic
  description: >-
    Nystagmus, sometimes present from early infancy together with poor visual
    acuity, giving an achromatopsia-like presentation; it was present in two of
    the four patients in the gene-discovery report.
  phenotype_term:
    preferred_term: Nystagmus
    term:
      id: HP:0000639
      label: Nystagmus
    onset:
      onset_category: INFANTILE
  evidence:
  - reference: PMID:25018096
    reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      in another sibling and in one isolated individual, poor visual acuity and nystagmus were present from early infancy, suggesting a form of ACHM.
    explanation: >-
      Nystagmus from early infancy in two of four affected individuals, which
      supports the infantile onset recorded here.
  - reference: PMID:25018096
    reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The proband (A-II:1) of family A presented with reduced visual acuity in early infancy and mild nystagmus.
    explanation: >-
      Individual-level report of early-infancy nystagmus.
  - reference: PMID:34065499
    reference_title: Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients showed impaired cone function leading to reduced visual acuity, color vision disturbances, photophobia or nystagmus.
    explanation: >-
      Nystagmus among the cone-dysfunction symptoms in an independent series.
- name: High myopia
  category: Ophthalmologic
  description: >-
    High myopia was reported in the Pakistani proband (PMID:39568138) and in
    one affected child of a Saudi sibship (PMID:41293231), where an affected
    adult in the same report also had myopia. Myopia is common in the general
    population and no study has tested whether it is part of the POC1B
    phenotype, so it is recorded without a frequency and is not wired to a
    mechanism.
  phenotype_term:
    preferred_term: High myopia
    term:
      id: HP:0011003
      label: High myopia
  evidence:
  - reference: PMID:39568138
    reference_title: A novel homozygous missense variant in POC1B causes cone dystrophy in a consanguineous Pakistani family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The proband, a 63-years old male, showed severely reduced day vision, a visual acuity of counting fingers (CF), color vision deficiency, high myopia and photophobia.
    explanation: >-
      High myopia in a homozygous POC1B patient.
  - reference: PMID:41293231
    reference_title: "POC1B-associated cone-rod dystrophy with bilateral optic disc swelling: A novel clinical observation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Cycloplegic refraction showed high myopia (4 diopters and 8 diopters for the right and left eyes, respectively) with mild astigmatism.
    explanation: >-
      High myopia in an affected child of a second family with a homozygous
      POC1B frameshift.
- name: Male infertility
  category: Reproductive
  description: >-
    Oligoasthenoteratozoospermia with male infertility, reported together with
    cone-rod dystrophy in two brothers homozygous for a POC1B frameshift
    variant. Whether it accompanies other POC1B genotypes is not known.
  phenotype_term:
    preferred_term: Male infertility
    term:
      id: HP:0003251
      label: Male infertility
  evidence:
  - reference: PMID:37070736
    reference_title: Homozygous frameshift variant in POC1B causes male infertility with oligoasthenoteratozoospermia in human and mice.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, whole-exome sequencing was performed to identify a homozygous frameshift variant (c.151delG) in POC1B in the two brothers who had been diagnosed with both CORD and OAT from a consanguineous family.
    explanation: >-
      Two brothers with both cone-rod dystrophy and
      oligoasthenoteratozoospermia.
genetic:
- name: POC1B
  association: Causal biallelic variant
  gene_term:
    preferred_term: POC1B
    term:
      id: hgnc:30836
      label: POC1B
  notes: >-
    The recurrent p.Arg106Pro allele was also reported homozygous in a family
    with Joubert syndrome, early-onset severe retinal dystrophy and polycystic
    kidney disease, which led to POC1B being proposed as a Joubert syndrome
    gene. Long-read genome sequencing later found a homozygous deep-intronic
    CEP290 variant, 1.28 Mb away and co-inherited in cis, that fully explains
    the syndromic features, and the authors withdrew the Joubert attribution.
    The syndromic presentation is therefore not part of this disease. No ClinGen
    gene-disease validity record was found for POC1B.
  evidence:
  - reference: PMID:25018096
    reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      in POC1B, encoding POC1 centriolar protein B, in three siblings with autosomal-recessive cone dystrophy or cone-rod dystrophy
    explanation: >-
      Identification of POC1B as the causal gene.
  - reference: PMID:40170356
    reference_title: Severe Joubert syndrome in family with homozygous POC1B p.Arg106Pro variant is due to a co-inherited deep-intronic mutation in the neighboring CEP290 gene.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      EOSRD and PKD can fully be ascribed to this CEP290 variant, whose effect outshines the "background" non-syndromic POC1B retinopathy and co-segregates with the severe syndromic phenotype. Our novel findings in this family no longer justify POC1B as a JBTS gene.
    explanation: >-
      Withdraws the earlier attribution of Joubert syndrome to POC1B and
      restricts the POC1B phenotype to non-syndromic retinopathy.
environmental: []
treatments:
- name: Low-vision support and photophobia management
  description: >-
    No disease-modifying treatment exists. Management is supportive: low-vision
    aids, tinted or filtered lenses for photophobia, and periodic
    ophthalmological follow-up. Genetic testing is what separates the disorder
    from incomplete achromatopsia, which it resembles.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Reduced visual acuity
    term:
      id: HP:0007663
      label: Reduced visual acuity
  - preferred_term: Photophobia
    term:
      id: HP:0000613
      label: Photophobia
animal_models:
- name: Zebrafish poc1b morphant
  species: Zebrafish
  genotype: poc1b translation-blocking morpholino knockdown
  publication: PMID:25018096
  description: >-
    Morpholino knockdown of poc1b produces small eyes, impaired optokinetic
    responses and shortened photoreceptor outer segments, partially rescued by
    wild-type but not patient-allele human POC1B mRNA.
  modeled_mechanisms:
  - target: Photoreceptor Basal Body and Connecting Cilium Defect
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    description: >-
      Knockdown shortens photoreceptor sensory cilia and outer segments.
    limitations: >-
      Transient morpholino knockdown during development rather than a stable
      germline allele, so it models a developmental ciliary defect and not the
      slowly progressive adult-onset degeneration seen in patients. The
      morphants also have ciliopathy features (curved body axis, heart defects)
      that patients do not show.
    evidence:
    - reference: PMID:25018096
      reference_title: Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        These ocular phenotypes could partially be rescued by wild-type human POC1B mRNA, but not by c.199_201del and c.317C>G mutant human POC1B mRNAs.
      explanation: >-
        Allele-specific rescue ties the zebrafish phenotype to the patient
        variants.
    - reference: PMID:26188096
      reference_title: Knockdown of poc1b causes abnormal photoreceptor sensory cilium and vision impairment in zebrafish.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        In addition, ciliopathy-associated developmental defects, such as small eyes, curved body axis, heart defects, and shortened cilia in Kupffer's vesicle, were observed as well.
      explanation: >-
        Documents the broader developmental ciliopathy features of the
        morphants, which are the main limitation of the model.
- name: Poc1b c.151delG knock-in mouse
  species: Mouse
  genotype: Poc1b c.151delG homozygous knock-in
  publication: PMID:37070736
  description: >-
    CRISPR knock-in of the frameshift allele found in two brothers with
    cone-rod dystrophy and oligoasthenoteratozoospermia.
  modeled_mechanisms:
  - target: Sperm Centriole and Flagellum Defect
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Male knock-in mice have oligoasthenoteratozoospermia with abnormal
      acrosome and flagellum formation.
    limitations: >-
      The abstract reports the reproductive phenotype only; a retinal phenotype
      in these mice is not described there, so the model's relevance to the
      cone-rod dystrophy is not established from this source.
    evidence:
    - reference: PMID:37070736
      reference_title: Homozygous frameshift variant in POC1B causes male infertility with oligoasthenoteratozoospermia in human and mice.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Notably, poc1bc.151delG/c.151delG KI male mice presented with OAT phenotype.
      explanation: >-
        The knock-in reproduces the human sperm phenotype.
datasets: []
notes: >-
  Two features recur in the literature and are easy to miss. First, the fundus
  is normal or nearly normal in most reported patients, and the disease has
  been initially diagnosed as incomplete achromatopsia; electroretinography and
  OCT are needed to recognise it. Second, rod function is often normal, so many
  patients are described as having cone dystrophy rather than cone-rod
  dystrophy; MONDO and OMIM name the disease cone-rod dystrophy 20 after the
  first reported families, and the entry covers the whole cone-predominant
  spectrum. Bilateral optic disc swelling with normal lumbar-puncture opening
  pressure has been reported in two siblings of one family (PMID:41293231);
  it is not recorded as a phenotype here because it rests on a single family
  and no HPO term distinguishes non-papilledema disc swelling. No GeneReviews
  chapter covers this disease.
📚

References & Deep Research

References

8
Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.
No top-level findings curated for this source.
Novel recessive cone-rod dystrophy caused by POC1B mutation.
No top-level findings curated for this source.
Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic Appearance.
No top-level findings curated for this source.
Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants.
No top-level findings curated for this source.
Mutation of POC1B in a severe syndromic retinal ciliopathy.
No top-level findings curated for this source.
Severe Joubert syndrome in family with homozygous POC1B p.Arg106Pro variant is due to a co-inherited deep-intronic mutation in the neighboring CEP290 gene.
No top-level findings curated for this source.
Homozygous frameshift variant in POC1B causes male infertility with oligoasthenoteratozoospermia in human and mice.
No top-level findings curated for this source.
An interaction network of inner centriole proteins organised by POC1A-POC1B heterodimer crosslinks ensures centriolar integrity.
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Review round 1: Cone-rod_Dystrophy_20 · 2026-10-11T21:39:22Z · View source

Changes made in response to the first review of PR 13706. Molecular function: POC1B's pathophysiology node now binds GO:0046982 protein heterodimerization activity (modifier DECREASED). The evidence is the 2024 study showing that POC1A-POC1B heterodimers organise the inner centriole scaffold (PMID:39543170). QuickGO lists only generic protein binding (GO:0005515) as an experimental molecular-function annotation for POC1B, so the heterodimerization term was chosen as the most specific sourced activity. Phenotypes: added Nystagmus (HP:0000639) with infantile onset, citing PMID:25018096 (early-infancy nystagmus in 2 of 4 patients) and PMID:34065499. The description now mentions the achromatopsia-like early-infancy presentation. Added High myopia (HP:0011003) from PMID:39568138 and PMID:41293231. It is left unwired and has no frequency, because no study tests whether myopia is part of the POC1B phenotype. Frequency VERY_FREQUENT was set on the light-adapted ERG and the OCT phenotypes, where the cited series report the finding in all patients. A central-scotoma table row from PMID:25018096 was added as evidence. Male infertility stays at HP:0003251, because HPO has no single oligoasthenoteratozoospermia term (a search returned only separate count, motility and morphology terms). Other: the supportive treatment modality is now DEVICE. The PMID:25044745 retinal immunostaining item is regraded to IN_VITRO, since it is ex vivo tissue staining. quote_role PRIMARY_RESULT was added to the Roosing synthesis sentence. Deep research: a falcon report was run and committed (research/Cone-rod_Dystrophy_20-deep-research-falcon.md). All 5 of its references resolved, none unresolved. The single term-validation flag is a placeholder label ('if available') attached to the correct MONDO ID. just preflight-dr could not run because the local MONDO build is absent and was not downloaded, given limited disk. As a manual named-entity check, the report names POC1B 47 times and no other causal gene, and it describes the correct families. Reconciliation against the report added a REFUTE item: Beck et al. found p.Arg106Pro localized normally to the centrosome in HEK293T cells, so the node description now calls the localization defect assay-dependent. The report also cites a 2024 Mexican IRD cohort (DOI:10.1186/s12886-023-03276-7) listing one homozygous POC1B frameshift; it was not added, because the finding sits in a table, not the abstract. Validated with just validate, validate-terms, count-verified-snippets, the offline gates, check-gene-activity-grounding (ref mode), compliance-connectivity, check-coarse-phenotypes and validate-disorders.

Create: Cone-rod_Dystrophy_20 · 2026-10-08T15:41:14Z · View source

New entry for cone-rod dystrophy 20 (MONDO:0014427), caused by biallelic POC1B variants. Kept as a standalone Disease: MONDO has it as a leaf under cone-rod dystrophy and no existing entry covers POC1B. Curated directly from PubMed literature; no deep-research report was run. Sources are the two 2014 gene-discovery papers (PMID:25018096, PMID:24945461), the Japanese seven-family cohort (PMID:31390656), further case series and case reports (PMID:34065499, 37246743, 33657974, 29220607, 39568138, 37227616), the POC1A/POC1B centriole study (PMID:23015594), the zebrafish knockdown studies (PMID:25018096, 26188096), and the oligoasthenoteratozoospermia family plus knock-in mouse (PMID:37070736). Lump/split: the reported Joubert-like presentation with homozygous p.Arg106Pro (PMID:25044745) was not split out and not recorded as a phenotype, because the same group later found a co-inherited deep-intronic CEP290 variant that fully explains the syndromic features and withdrew the Joubert attribution (PMID:40170356). This is recorded in the genetic notes. A two-sibling report of optic disc swelling (PMID:41293231) is mentioned in notes only. Pathograph: POC1B variants -> photoreceptor basal body / connecting cilium defect -> cone-predominant photoreceptor degeneration -> retinal phenotypes, with a separate branch to the sperm flagellum defect and male infertility. No GeneReviews chapter or ClinGen gene-disease validity record exists for POC1B. The treatment entry (supportive care) is uncited because no study evaluates treatment. Validated with just validate, validate-terms, count-verified-snippets, the offline entity-ref, causal-target, duplicate-key and enum gates, and validate-disorders.

Falcon ▸
Disease Characteristics Research Template
Edison Scientific Literature 25 citations 2026-10-08T16:11:40.933713

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Characteristics Research Template

Target Disease

  • Disease Name: Cone-rod dystrophy 20
  • MONDO ID: MONDO:0014427 (if available)
  • Category: Mendelian

Research Objectives

Please provide a comprehensive research report on Cone-rod dystrophy 20 covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.


1. Disease Information

Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

  • What is the disease? Provide a concise overview.
  • What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
  • What are the common synonyms and alternative names?
  • Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

2. Etiology

  • Disease Causal Factors: What are the primary causes? (genetic, environmental, infectious, mechanistic)
  • Risk Factors:

    Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases

  • Genetic risk factors (causal variants, susceptibility loci, modifier genes)
  • Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
  • Protective Factors:

    Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases

  • Genetic protective factors (protective variants, modifier alleles)
  • Environmental protective factors (diet, lifestyle, exposures that reduce risk)
  • Gene-Environment Interactions: How do genetic and environmental factors interact to influence disease?

    Search first: CTD, PubMed, PheGenI, GxE databases

3. Phenotypes

Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities

For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype

4. Genetic/Molecular Information

  • Causal Genes: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)

    Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene

  • Pathogenic Variants:
  • Affected genes (gene symbols, HGNC IDs) > Search first: OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
  • Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines) > Search first: ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
  • Variant type/class (missense, frameshift, nonsense, splice-site, structural)
  • Allele frequency in population databases > Search first: gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
  • Somatic vs germline origin > Search first: COSMIC (somatic), ClinVar, ICGC, TCGA
  • Functional consequences (loss of function, gain of function, dominant negative)
  • Modifier Genes: Genes that modify disease severity or expression
  • Epigenetic Information: DNA methylation, histone modifications, chromatin changes affecting disease

    Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth

  • Chromosomal Abnormalities: Large-scale genetic changes (aneuploidy, translocations, inversions)

    Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

5. Environmental Information

  • Environmental Factors: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)

    Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases

  • Lifestyle Factors: Behavioral factors (smoking, diet, exercise, alcohol consumption)

    Search first: CDC databases, WHO, PubMed, NHANES

  • Infectious Agents: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)

    Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

6. Mechanism / Pathophysiology

Present this section as an ordered causal chain first, then the detail below. Open with a numbered sequence of mechanistic steps running from the initiating lesion (mutation, exposure, infection) to the clinical manifestation, one step per line, each naming what it causes next. State the causal verb explicitly ("leads to", "results in") and say where a step is inferred rather than demonstrated. Where the mechanism branches, show the branch. The categories below are a checklist of what to cover within those steps, not the organizing structure — a step may draw on several of them, and a category may contribute to several steps.

  • Molecular Pathways: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)

    Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc

  • Cellular Processes: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)

    Search first: Gene Ontology (GO), Reactome, KEGG, PubMed

  • Protein Dysfunction: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)

    Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold

  • Metabolic Changes: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)

    Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA

  • Immune System Involvement: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)

    Search first: ImmPort, Immunome Database, IEDB, Gene Ontology

  • Tissue Damage Mechanisms: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)

    Search first: PubMed, Gene Ontology, Reactome

  • Biochemical Abnormalities: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)

    Search first: BRENDA, UniProt, KEGG, OMIM, PubMed

  • Epigenetic Changes: DNA methylation, histone modifications affecting gene expression in disease

    Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth

  • Molecular Profiling (if available):
  • Transcriptomics/gene expression changes > Search first: GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
  • Proteomics findings > Search first: PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
  • Metabolomics signatures > Search first: MetaboLights, Metabolomics Workbench, HMDB, METLIN
  • Lipidomics alterations > Search first: LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
  • Genomic structural features > Search first: UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
  • Advanced Technologies (if applicable):
  • Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity) > Search first: Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
  • Spatial transcriptomics findings > Search first: GEO, Spatial Research, Vizgen, 10x Genomics data
  • Multi-omics integration results > Search first: TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
  • Functional genomics screens (CRISPR, RNAi) > Search first: DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types

7. Anatomical Structures Affected

  • Organ Level:
  • Primary organs directly affected
  • Secondary organ involvement (complications, secondary effects)
  • Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)

    Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT

  • Tissue and Cell Level:
  • Specific tissue types affected (epithelial, connective, muscle, nervous)
  • Specific cell populations targeted (with Cell Ontology terms)

    Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB

  • Subcellular Level:
  • Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)

    Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas

  • Localization:
  • Specific anatomical sites (with UBERON terms) > Search first: FMA, Uberon, NeuroNames (for brain), SNOMED CT
  • Lateralization (unilateral, bilateral, asymmetric) > Search first: HPO, clinical literature, imaging databases

8. Temporal Development

  • Onset:
  • Typical age of onset (congenital, pediatric, adult, geriatric)
  • Onset pattern (acute, subacute, chronic, insidious)

    Search first: OMIM, Orphanet, HPO, PubMed

  • Progression:
  • Disease stages (early, intermediate, advanced, end-stage) > Search first: Cancer Staging Manual (AJCC), WHO classifications, PubMed
  • Progression rate (rapid, slow, variable)
  • Disease course pattern (episodic, relapsing-remitting, progressive, stable)
  • Disease duration (self-limited, chronic lifelong)

    Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM

  • Patterns:
  • Remission patterns (spontaneous, treatment-induced) > Search first: Clinical trial databases, disease registries, PubMed
  • Critical periods (time windows of vulnerability or opportunity for intervention) > Search first: PubMed, developmental biology databases, clinical guidelines

9. Inheritance and Population

  • Epidemiology:
  • Prevalence (cases per 100,000 at given time)
  • Incidence (new cases per 100,000 per year)

    Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries

  • For Genetic Etiology:
  • Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic) > Search first: OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
  • Penetrance (complete, incomplete, age-dependent) > Search first: ClinVar, OMIM, PubMed, ClinGen
  • Expressivity (variable, consistent) > Search first: OMIM, ClinVar, PubMed
  • Genetic anticipation (increasing severity in successive generations) > Search first: OMIM, PubMed (especially for repeat expansion disorders)
  • Germline mosaicism > Search first: ClinVar, OMIM, genetic counseling literature, PubMed
  • Founder effects (population-specific mutations) > Search first: gnomAD, population genetics databases, PubMed
  • Consanguinity role > Search first: OMIM, population studies, genetic counseling resources
  • Carrier frequency > Search first: gnomAD, carrier screening databases, GeneReviews, GTR
  • Population Demographics:
  • Affected populations (ethnic or demographic groups with higher prevalence) > Search first: gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
  • Geographic distribution (endemic areas, regional variation) > Search first: WHO, CDC, GBD, Orphanet, geographic epidemiology databases
  • Geographic distribution of specific variants
  • Sex ratio (male:female) > Search first: Disease registries, OMIM, PubMed, epidemiological databases
  • Age distribution of affected individuals > Search first: CDC, disease registries, SEER, Orphanet

10. Diagnostics

  • Clinical Tests:
  • Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays) > Search first: LOINC, LabTests Online, PubMed
  • Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers) > Search first: FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
  • Imaging studies (X-ray, CT, MRI, PET, ultrasound) > Search first: RadLex, DICOM, Radiopaedia, imaging databases
  • Functional tests (pulmonary function, cardiac stress tests) > Search first: LOINC, clinical guidelines, PubMed
  • Electrophysiology (EEG, EMG, ECG, nerve conduction studies) > Search first: LOINC, clinical neurophysiology databases, PubMed
  • Biopsy findings (histopathology, immunohistochemistry) > Search first: SNOMED CT, College of American Pathologists resources, PubMed
  • Pathology findings (microscopic examination) > Search first: SNOMED CT, Digital Pathology databases, PubMed
  • Genetic Testing:

    Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen

  • Overview of recommended genetic testing approach
  • Whole genome sequencing (WGS) utility > Search first: GTR, ClinVar, GEL (Genomics England), gnomAD
  • Whole exome sequencing (WES) utility > Search first: GTR, ClinVar, OMIM, GeneMatcher
  • Gene panels (which panels, which genes) > Search first: GTR, ClinVar, laboratory-specific databases
  • Single gene testing > Search first: GTR, ClinVar, OMIM, GeneReviews
  • Chromosomal microarray (CMA) > Search first: DECIPHER, ClinVar, dbVar, ECARUCA
  • Karyotyping > Search first: Chromosome Abnormality Database, ClinVar, cytogenetics resources
  • FISH > Search first: ClinVar, cytogenetics databases, PubMed
  • Mitochondrial DNA testing > Search first: MITOMAP, MSeqDR, ClinVar, GTR
  • Repeat expansion testing > Search first: GTR, ClinVar, repeat expansion databases, PubMed
  • Omics-Based Diagnostics (if applicable):
  • RNA sequencing / transcriptomics > Search first: GEO, ArrayExpress, GTEx, RNA-seq databases
  • Proteomics > Search first: PRIDE, ProteomeXchange, FDA Biomarker database
  • Metabolomics > Search first: MetaboLights, Metabolomics Workbench, HMDB
  • Epigenomics > Search first: GEO, ENCODE, Roadmap Epigenomics, MethBase
  • Liquid biopsy > Search first: COSMIC, ClinVar, liquid biopsy databases, PubMed
  • Clinical Criteria:
  • Standardized diagnostic criteria (DSM, ICD, society guidelines) > Search first: DSM-5, ICD-11, clinical society guidelines, UpToDate
  • Differential diagnosis (other conditions to rule out, with distinguishing features) > Search first: DynaMed, UpToDate, clinical decision support systems
  • Screening:
  • Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening) > Search first: ACMG recommendations, CDC newborn screening, GTR

11. Outcome/Prognosis

  • Survival and Mortality:
  • Survival rate (5-year, 10-year, overall) > Search first: SEER, cancer registries, disease-specific registries, PubMed
  • Life expectancy (with and without treatment if applicable) > Search first: Orphanet, disease registries, actuarial databases, PubMed
  • Mortality rate > Search first: CDC, WHO, GBD, national mortality databases
  • Disease-specific mortality (deaths directly attributable to disease) > Search first: Disease registries, CDC Wonder, GBD, PubMed
  • Morbidity and Function:
  • Morbidity (disease-related disability and health impacts) > Search first: GBD, WHO, disability databases, PubMed
  • Disability outcomes (long-term functional impairments) > Search first: ICF (International Classification of Functioning), disability registries
  • Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools) > Search first: EQ-5D database, SF-36, PROMIS, PubMed
  • Disease Course:
  • Complications (secondary problems: infections, organ failure, etc.) > Search first: ICD codes, disease registries, clinical databases, PubMed
  • Recovery potential (likelihood and extent of recovery, with vs without treatment) > Search first: Natural history studies, rehabilitation databases, PubMed
  • Prediction:
  • Prognostic factors (age, disease severity, biomarkers, treatment response) > Search first: Prognostic models databases, clinical calculators, PubMed
  • Prognostic biomarkers (molecular markers predicting disease course) > Search first: FDA Biomarker database, PubMed, cancer prognostic databases

12. Treatment

  • Pharmacotherapy:
  • Pharmacological treatments (drug names, drug classes, mechanisms of action) > Search first: DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
  • Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity) > Search first: PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
  • Advanced Therapeutics:
  • Gene therapy (viral vectors, CRISPR, gene replacement, gene editing) > Search first: ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
  • Cell therapy (stem cell transplant, CAR-T, cellular therapeutics) > Search first: ClinicalTrials.gov, FDA cell therapy database, FACT standards
  • RNA-based therapies (ASOs, siRNA, mRNA therapies) > Search first: ClinicalTrials.gov, FDA approvals, PubMed
  • Targeted therapies (treatments directed at specific molecular targets) > Search first: My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
  • Immunotherapies (checkpoint inhibitors, monoclonal antibodies) > Search first: Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
  • Surgical and Interventional:
  • Surgical interventions (types of surgery, timing, outcomes) > Search first: CPT codes, surgical registries, clinical guidelines, PubMed
  • Supportive and Rehabilitative:
  • Supportive care (symptom management, pain control, nutrition) > Search first: Clinical guidelines, Cochrane Library, PubMed
  • Rehabilitation (physical therapy, occupational therapy, speech therapy) > Search first: Rehabilitation medicine databases, clinical guidelines, PubMed
  • Experimental:
  • Experimental treatments in clinical trials (with NCT identifiers if available) > Search first: ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
  • Treatment Outcomes:
  • Treatment response rates > Search first: Clinical trial databases, FDA reviews, systematic reviews, PubMed
  • Side effects and adverse events > Search first: FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
  • Treatment Strategy:
  • Treatment algorithms (clinical pathways, decision trees) > Search first: Clinical practice guidelines, NCCN Guidelines, UpToDate
  • Combination therapies > Search first: ClinicalTrials.gov, treatment guidelines, PubMed
  • Personalized medicine approaches (genotype-guided treatment) > Search first: My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest NCIT (NCI Thesaurus) clinical-intervention terms where applicable.

13. Prevention

  • Prevention Levels:
  • Primary prevention (preventing disease occurrence: vaccination, risk factor modification) > Search first: CDC, WHO, USPSTF recommendations, Cochrane Library
  • Secondary prevention (early detection and treatment: screening programs, early intervention) > Search first: USPSTF, CDC screening guidelines, WHO
  • Tertiary prevention (preventing complications in those with disease) > Search first: Clinical guidelines, disease management protocols, PubMed
  • Immunization: Vaccine strategies (if applicable)

    Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database

  • Screening and Early Detection:
  • Screening programs (population-based: newborn screening, cancer screening) > Search first: CDC screening programs, USPSTF, cancer screening databases
  • Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing) > Search first: ACMG recommendations, ACOG guidelines, GTR
  • Risk stratification (identifying high-risk individuals for targeted prevention) > Search first: Risk prediction models, clinical calculators, PubMed
  • Behavioral Interventions: Lifestyle modifications to reduce risk

    Search first: CDC, WHO, behavioral intervention databases, Cochrane Library

  • Counseling: Genetic counseling (risk assessment, family planning guidance)

    Search first: NSGC resources, ACMG guidelines, GeneReviews

  • Public Health:
  • Public health interventions (sanitation, vector control, health education) > Search first: CDC, WHO, public health databases, PubMed
  • Environmental interventions (reducing environmental risk factors) > Search first: EPA databases, WHO environmental health, PubMed
  • Prophylaxis: Preventive medications or procedures

    Search first: Clinical guidelines, FDA approvals, PubMed

14. Other Species / Natural Disease

  • Taxonomy: Species affected (with NCBI Taxon identifiers)

    Search first: NCBI Taxonomy

  • Breed: Specific breeds affected (with VBO identifiers if applicable)

    Search first: VBO (Vertebrate Breed Ontology)

  • Gene: Orthologous genes in other species (with NCBI Gene IDs)

    Search first: NCBI Gene

  • Natural Disease:
  • Naturally occurring disease in other species (companion animals, wildlife) > Search first: OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
  • Veterinary relevance and importance in animal health > Search first: OMIA, veterinary databases, PubMed
  • Comparative Biology:
  • Comparative pathology (similarities and differences across species) > Search first: OMIA, comparative pathology databases, PubMed
  • Evolutionary conservation of disease mechanisms > Search first: HomoloGene, OrthoMCL, Alliance of Genome Resources
  • Transmission (if applicable):
  • Zoonotic potential > Search first: CDC zoonotic diseases, WHO zoonoses, GIDEON
  • Cross-species susceptibility > Search first: NCBI Taxonomy, veterinary databases, PubMed

15. Model Organisms

  • Model Types:
  • Model organism type (mammalian, invertebrate, cellular, in vitro) > Search first: Alliance of Genome Resources, model organism databases
  • Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs) > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
  • Induced models (drug treatment, surgical intervention, environmental manipulation) > Search first: MGI, model organism databases, PubMed
  • Genetic Models:
  • Types available (knockout, knock-in, transgenic, conditional, humanized) > Search first: MGI, IMPC, KOMP, EuMMCR, IMSR
  • Model Characteristics:
  • Phenotype recapitulation (how well model reproduces human disease features) > Search first: Model organism databases, comparative studies, PubMed
  • Model limitations (aspects of human disease not captured) > Search first: Model organism databases, PubMed, review articles
  • Applications:
  • Research applications (what aspects of disease can be studied) > Search first: Model organism databases, PubMed
  • Resources:
  • Model databases > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

Citation Requirements

  • Cite primary literature (PMID preferred) for all mechanistic and clinical claims
  • Prioritize recent reviews and landmark papers
  • Include direct quotes from abstracts where possible to support key statements
  • Distinguish evidence source types: human clinical, model organism, in vitro, computational

Output Format

Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, NCIT, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (NCIT terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details

Cone-rod dystrophy 20: disease-characteristics research report

Scope and evidence standard. Cone-rod dystrophy 20 (CORD20) is a rare, autosomal-recessive POC1B-associated retinal disorder. Its best-documented presentation is progressive cone dysfunction, sometimes followed by rod dysfunction. Evidence remains concentrated in small clinical series and experimental models; findings for cone-rod dystrophy generally, or for a different POC1B-associated syndrome, must not automatically be assigned to CORD20. The observations below derive from published, aggregated research—not an individual electronic health record. (roosing2014disruptionofthe pages 1-2, roosing2014disruptionofthe pages 4-5, beck2014mutationofpoc1b pages 1-2)

1. Disease information and identifiers

Definition. CORD20 belongs to the inherited retinal dystrophies. Cone-predominant disease impairs central visual acuity and color vision; when rods become involved, peripheral vision and night vision can also deteriorate. Its clinical spectrum includes presentations diagnosed initially as cone dystrophy or achromatopsia-like cone dysfunction before progression becomes evident. The original investigators described their families as having nonsyndromic autosomal-recessive cone dystrophy or cone-rod dystrophy. (roosing2014disruptionofthe pages 1-2, roosing2014disruptionofthe pages 5-7, roosing2014disruptionofthe pages 10-11)

Knowledge-base identifiers: disease OMIM 615973; causal-gene OMIM 614784, POC1B; supplied MONDO:0014427, whose current mapping should be checked against the live MONDO release before ingestion. Useful names are cone-rod dystrophy 20, CORD20, POC1B-associated cone-rod dystrophy, and, for the broader allelic clinical spectrum rather than a strict synonym, POC1B-associated cone dystrophy. A subtype-specific Orphanet number, MeSH descriptor, or ICD-10/ICD-11 code could not be independently established from the retrieved evidence; a broad retinal-dystrophy billing code would not uniquely identify CORD20. POC1B is also called WDR51B or PIX1 in an early report. (beck2014mutationofpoc1b pages 1-2, roosing2014disruptionofthe pages 1-2)

2. Etiology, risk, protection, and environment

Established cause: inherited pathogenic variants affecting both POC1B alleles, either homozygously or as variants in trans, disrupt a protein required for centriole/basal-body and photoreceptor-cilium integrity. The documented familial risk factor is parental transmission of two affected alleles; a heterozygous relative in the original family was unaffected. A consanguineous family has also been reported, but consanguinity is not required: the original Turkish family was explicitly nonconsanguineous. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 1-2, beck2014mutationofpoc1b pages 1-2)

Unestablished: a CORD20-specific toxin, pathogen, occupational or dietary risk factor; protective variant, supplement, medication, or behavior; quantified gene–environment interaction; or confirmed human modifier gene. Different clinical outcomes reported with p.Arg106Pro suggest that background effects may exist, but neither a modifier nor an environmental cause was demonstrated. FAM161A is an experimentally observed interacting protein, not an established CORD20 modifier. Ordinary light protection may improve comfort in photophobia, but should not be claimed to prevent genetically driven degeneration. (beck2014mutationofpoc1b pages 1-2, roosing2014disruptionofthe pages 7-9)

3. Phenotypes and clinical frequency

The most reliable disease-specific phenotype denominator in the foundational report is four affected individuals, not a population sample. In that series, final labels were cone dystrophy in 2/4 and cone-rod dystrophy in 2/4; these are sample descriptions, not population frequencies. The table below preserves ages at examination, because an age at which a finding was measured is not necessarily the age it began. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe media 421751db)

Patient Genotype First documented visual acuity (age) Last documented visual acuity (age) ERG findings (age) Final diagnosis
A-II:1 Homozygous POC1B c.317C>G (p.Arg106Pro) RE 0.16; LE 0.16 (3 years) RE counting fingers; LE 0.1 (16 years) Nonrecordable cone responses; normal rod responses (9 and 13 years) Cone dystrophy (COD)
A-II:3 Homozygous POC1B c.317C>G (p.Arg106Pro) RE 0.8; LE 0.8 (10 years) RE 0.3; LE 0.2 (19 years) Severely reduced cone responses; normal rod responses (11 years) Cone dystrophy (COD)
A-II:4 Homozygous POC1B c.317C>G (p.Arg106Pro) RE 1.0; LE 0.8 (3 years) RE 0.16; LE 0.2 (9 years) Nonrecordable cone responses; severely reduced rod responses (6 years) Cone-rod dystrophy (CRD)
B-II:1 Compound heterozygous POC1B c.199_201del (p.Gln67del) and c.810+1G>T RE 0.2; LE 0.2 (14 years) RE 0.05; LE 0.05 (60 years) Nonrecordable cone responses with normal rod responses (14 years); nonrecordable cone responses with significantly reduced rod responses (55 years) Cone-rod dystrophy (CRD)
Total (n=4) — — — — 2 COD; 2 CRD

Table: Clinical findings from the four affected individuals in Roosing et al.’s original 2014 POC1B report, including exact examination ages and progression from cone-predominant to cone-rod dysfunction (roosing2014disruptionofthe pages 4-5).

Symptoms: reduced central vision was documented early in some patients and worsened over time; color-vision deficits were recorded in three examined individuals, whereas testing was unavailable for the fourth. Photophobia was reported in the patient initially diagnosed with achromatopsia. Night blindness and peripheral visual difficulties are plausible when rods are affected, but their CORD20-specific frequencies were not measured in these four patients. Signs and test abnormalities: nystagmus occurred in 2/4; central scotoma and some peripheral field constriction were reported in each of the four patients at their documented examinations; cone electroretinographic responses were severely reduced or unrecordable in 4/4; rod responses were severely or significantly reduced in 2/4 at reported examinations. Peripheral pigmentary change and ellipsoid-zone abnormalities were age-dependent observations, not obligatory diagnostic signs. These small fractions should not be entered as generalizable HPO prevalence estimates. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 5-7)

Suggested HPO concepts, pending identifier validation against the current HPO release: cone-rod dystrophy; cone dystrophy; reduced visual acuity; impaired color vision; photophobia; nystagmus; central scotoma; peripheral visual-field constriction; abnormal cone electroretinogram; abnormal rod electroretinogram; retinal pigment epithelial atrophy; bone-spicule retinal pigmentation. For frequently used codes, candidates include HP:0000551 (abnormality of color vision), HP:0000639 (nystagmus), and HP:0000613 (photophobia); validate exact concept/code pairing before loading. No behavioral or systemic phenotype is established as a defining feature of nonsyndromic CORD20. Central-vision loss and photophobia have obvious implications for reading, navigation, and visually demanding work, but no CORD20-specific EQ-5D, SF-36, PROMIS, or phenotype-by-phenotype quality-of-life estimates were found. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 5-7, roosing2014disruptionofthe pages 1-2)

Important boundary: a separate 2014 report described a family with homozygous POC1B p.Arg106Pro and severe congenital visual dysfunction plus Joubert-like cerebellar abnormalities and markedly cystic kidneys. Those systemic findings belong to an allelic syndromic POC1B ciliopathy report; they are neither proven frequent nor defining for CORD20. Evaluate systemic findings on their own merits rather than labeling all CORD20 patients as having Joubert syndrome. (beck2014mutationofpoc1b pages 1-2, beck2014mutationofpoc1b pages 3-4)

4. Genetic and molecular information

The original report established three POC1B alleles. Three affected siblings carried homozygous c.317C>G, p.Arg106Pro; an unrelated person carried c.199_201del, p.Gln67del, together with splice-donor c.810+1G>T. The first is a missense change, the second an in-frame amino-acid deletion, and the third a splice-site variant. Patient RNA showed that c.810+1G>T produced exon-skipping transcripts predicted to encode p.Phe188Aspfs*73 or p.Val226Glyfs*30. At the time, c.317C>G was absent in 189 ethnicity-matched controls, and the two family-B variants were absent in 149 matched controls and the cited exome database; these historical observations are not current gnomAD frequencies. The evidence supports inherited germline, rather than somatic, disease. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 1-2)

2024 clinical update: a Northeast Mexico cohort of 126 unrelated inherited-retinal-dystrophy patients used a panel covering at least 293 genes. Its table listed a patient with homozygous POC1B NM_172240.2:c.144del, p.Lys48Asnfs*16, designated pathogenic by the authors, and another with heterozygous c.676+1G>A, designated pathogenic, plus heterozygous c.320G>T, p.Ser107Ile, designated a variant of uncertain significance (VUS). The latter pair's trans phase was not established in the retrieved table: do not promote p.Ser107Ile to pathogenic or regard the case as conclusively solved on that evidence alone. The study-wide 74.6% diagnostic yield concerns the entire IRD cohort, not CORD20. Numerically, two listed POC1B patient IDs among 126 ascertainment-selected patients are not a prevalence estimate. (cruz2024spectrumofvariants pages 4-5, cruz2024spectrumofvariants pages 2-4, cruz2024spectrumofvariants pages 1-2)

Classification and annotation cautions: classify each allele using the current laboratory's ACMG/AMP interpretation, transcript, segregation, and updated population-frequency evidence. The two 2014 amino-acid changes disrupted localization and FAM161A binding in experimental assays, but a single universal molecular effect for every POC1B allele is unproven. No disease-specific epigenetic lesion, validated structural chromosomal abnormality, somatic mechanism, or established modifier locus was identified. Record POC1B / OMIM 614784 as verified; confirm the HGNC numeric accession directly with HGNC rather than inferring one. (roosing2014disruptionofthe pages 7-9, sala2024aninteractionnetwork pages 1-2, cruz2024spectrumofvariants pages 4-5)

5. Environmental information

No infectious organism causes this Mendelian disease, and no toxin, radiation exposure, pollution, smoking history, alcohol exposure, or nutritional factor has been demonstrated to initiate CORD20. The original report noted treated hypertension in one older patient with normal renal function; this observation should not be construed as either an etiological exposure or evidence that kidney disease characterizes CORD20. Environmental counseling should distinguish general ocular health and adaptation from proven prevention of POC1B disease. (roosing2014disruptionofthe pages 5-7)

6. Mechanism and pathophysiology

Ordered causal chain, with evidentiary boundaries:

  1. Biallelic damaging POC1B alleles lead to altered POC1B protein or transcripts; c.810+1G>T leads to exon skipping, whereas p.Arg106Pro and p.Gln67del affect its WD40 region. Demonstrated for the reported alleles. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 1-2)
  2. Altered POC1B leads to impaired basal-body enrichment and/or reduced binding to FAM161A in the original cellular assays. Demonstrated in overexpression and biochemical models, not measured directly in affected photoreceptors. A different study did not observe loss of centrosomal localization for p.Arg106Pro, so localization loss is assay-dependent and should not be presented as universal. (roosing2014disruptionofthe pages 5-7, roosing2014disruptionofthe pages 7-9, beck2014mutationofpoc1b pages 6-8)
  3. Deficient basal-body/centriole function leads to defective ciliogenesis or photoreceptor-cilium organization. Knockdown experiments demonstrate ciliary abnormalities; 2024 cell-biological work independently places POC1B in a POC1A–POC1B/POC5/FAM161A inner-scaffold interaction network. Inferring that precisely the same scaffold defect occurs in every human CORD20 variant remains untested. (zhang2015knockdownofpoc1b pages 1-5, sala2024aninteractionnetwork pages 1-2, beck2014mutationofpoc1b pages 6-8)
  4. Ciliary disruption leads to abnormal outer segments and impaired visual responses. Zebrafish poc1b depletion produced shortened or absent photoreceptor outer segments and impaired optokinetic responses; wild-type human POC1B, unlike two disease-associated mutant constructs, partially rescued the ocular phenotype. Demonstrated in a knockdown model. (roosing2014disruptionofthe pages 7-9, roosing2014disruptionofthe pages 1-2)
  5. Abnormal cone function results in impaired acuity, color vision and cone ERG, with a branch in which rod involvement results in reduced rod ERG and broader retinal/field degeneration. The clinical association is demonstrated, while the precise cell-death sequence connecting individual alleles to each patient's progression is inferred. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 5-7)

Mechanistic detail. The upstream biology is protein assembly and microtubule/ciliary structural maintenance rather than a demonstrated CORD20-specific Wnt, MAPK, mTOR, or PI3K–AKT signaling lesion. In the 2024 primary mechanistic study, POC1A–POC1B heterodimers linked the centriolar inner scaffold: the POC1B WD40 domain lay nearer the centriole wall; POC1A interacted with POC5; and FAM161A and MDM1 participated in the proposed network. Removing POC1A or POC1B damaged centriole microtubules; removing both severely compromised centriole integrity. These cell-model observations refine a plausible upstream mechanism but do not constitute a CORD20 patient treatment result. (sala2024aninteractionnetwork pages 1-2, sala2024aninteractionnetwork pages 9-10)

Suggested GO biological processes: centriole organization; microtubule-based process; cilium assembly; photoreceptor cell maintenance; visual perception. Suggested GO cellular components: centriole; centrosome; ciliary basal body; photoreceptor connecting cilium; photoreceptor outer segment. Suggested CL cell concepts: retinal cone cell; retinal rod cell; retinal pigment epithelial cell—note that RPE-1 was also an experimental cell line, not proof of primary RPE pathology in CORD20. Validate exact GO/CL accession numbers against ontology releases. Specific enzyme deficiency, metabolomic/lipidomic signature, immune activation, epigenetic signature, patient-derived single-cell or spatial transcriptomic profile, and CORD20-specific CRISPR screen were not established in the retrieved studies. POC1B interaction assays are targeted protein experiments, not patient proteomic profiling. (roosing2014disruptionofthe pages 5-7, roosing2014disruptionofthe pages 7-9, zhang2015knockdownofpoc1b pages 1-5, sala2024aninteractionnetwork pages 1-2)

7. Anatomical structures affected

Primary organ and tissue: the bilateral neural retina, particularly cone and then, in some patients, rod photoreceptors. Observed disease findings include peripheral retinal pigment epithelial changes and outer-retinal ellipsoid-zone alterations; these are not evidence that retinal pigment epithelium is the primary mutant-cell population. At the subcellular level, focus on the centriole/ciliary basal body adjacent to the photoreceptor connecting cilium and its outer segment. Suggested UBERON concepts are eye, retina, macula, and retinal photoreceptor layer; confirm their accession IDs before database insertion. There is no evidence for a characteristic left–right asymmetric CORD20 pattern. Brain and kidney involvement is documented in an allelic syndromic report, not established as typical of nonsyndromic CORD20. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 5-7, beck2014mutationofpoc1b pages 1-2)

8. Temporal development

Onset and trajectory: early-infancy visual complaints occurred in one originally reported sibling, while childhood presentations and a patient initially assessed at 14 years were also described. The pattern is generally chronic and progressive, but rate is variable. One subject's visual acuity fell from 0.2 in each eye at age 14 to 0.05 in each eye at age 60; rod ERG was normal at 14 and significantly reduced at 55. Another had severely reduced rod responses already at 6. Consequently, no fixed age for transition from cone to cone-rod disease should be imposed. Proposed early cone-predominant, later mixed cone/rod, and advanced peripheral-degeneration stages are descriptive, not a validated CORD20 staging system. No spontaneous remission or CORD20-specific intervention window has been demonstrated. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 5-7)

9. Inheritance and population

Inheritance: autosomal recessive, supported by homozygous affected siblings, unaffected heterozygous relatives, and a separately observed compound-heterozygous patient. For counseling of a confirmed two-carrier couple, the usual Mendelian risks are 25% affected, 50% carrier, and 25% inheriting neither familial allele per pregnancy, assuming both variants are pathogenic and segregate as expected; these are genetic probabilities, not measured cohort incidence. Intrafamilial and allelic expressivity varies, but penetrance, germline-mosaicism frequency, carrier frequency, anticipation, founder effect, population sex ratio, and geographic distribution cannot be estimated reliably from available CORD20 data. Both sexes were affected in the original series (two female, two male), which does not establish a 1:1 population ratio. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 1-2)

Epidemiology caution: the original article's 1:30,000–1:40,000 estimate refers to the broad category of inherited cone disorders, not CORD20. Likewise, a 2024 article's approximate 1:2,000–3,000 concerns inherited retinal dystrophies collectively. Neither figure can be used as CORD20 prevalence or incidence. No validated CORD20-specific population prevalence, incidence, or carrier-frequency estimate was located. (roosing2014disruptionofthe pages 1-2, cruz2024spectrumofvariants pages 1-2)

10. Diagnostics and differential diagnosis

Clinical assessment: take a pedigree and characterize visual-acuity change, color vision, photophobia, fields, and night-vision complaints. Fundus examination, fundus autofluorescence, optical coherence tomography, and full-field photopic and scotopic electroretinography establish retinal distribution and cone-versus-rod functional involvement; use serial examinations where a stationary-appearing childhood phenotype might actually progress. The original investigators used acuity, color testing, Goldmann perimetry, fundus imaging, OCT, and ERG. OCT could initially show a preserved ellipsoid zone, so a relatively normal early fundus does not exclude the molecular diagnosis. No blood enzyme assay, circulating biomarker, or diagnostic retinal biopsy is established for CORD20. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 5-7, roosing2014disruptionofthe pages 1-2)

Molecular confirmation: use a comprehensive inherited-retinal-disease multigene panel including POC1B, with sequence-variant and copy-number detection where offered, or exome/genome sequencing if panel testing is negative or the presentation is atypical. Confirm candidate genotypes and phase through parental/relative testing; interpret splice variants using validated RNA analysis where clinically justified. The discovery series used exome sequencing, segregation and patient-derived RNA, and the 2024 cohort used a broad retinal-disease panel; these are demonstrated applications, not proof that one platform is always superior. Single-gene POC1B testing may be appropriate for known familial variants. Chromosomal microarray, routine karyotyping, FISH, mitochondrial sequencing and repeat-expansion assays are not established first-line tests specifically for CORD20, although broader differential findings can warrant them. No validated CORD20-specific clinical RNA-seq, proteomic, metabolomic, epigenomic, or liquid-biopsy diagnostic is available. (roosing2014disruptionofthe pages 4-5, cruz2024spectrumofvariants pages 4-5, cruz2024spectrumofvariants pages 1-2)

Differential diagnosis: distinguish progressive cone dystrophy/early cone-rod dystrophy from stationary achromatopsia using serial acuity and cone/rod ERGs; distinguish rod-predominant retinitis pigmentosa using symptom sequence and ERG; and pursue other inherited cone-rod-dystrophy genes through broad sequencing. Particularly severe infantile visual impairment plus cerebellar or renal disease warrants evaluation for syndromic retinal ciliopathy rather than assigning the presentation to uncomplicated CORD20. The original report itself documented clinical reclassification with longitudinal follow-up. (roosing2014disruptionofthe pages 5-7, beck2014mutationofpoc1b pages 1-2, roosing2014disruptionofthe pages 1-2)

11. Outcome and prognosis

Most substantiated outcome: progressive visual impairment, with potentially substantial decline in central acuity and eventual rod dysfunction in some individuals. The four-person series supplies individual trajectories, not reliable rates of legal blindness, an average annual decline, or a validated prognostic biomarker. Loss of reading ability or independent mobility is clinically plausible as function deteriorates, but no disease-specific disability or quality-of-life score was retrieved. CORD20-specific survival, life expectancy and disease-attributable mortality are unreported; do not transfer childhood deaths in a severe renal–neurological POC1B family to patients with isolated retinal CORD20. No established curative recovery or genotype-specific treatment-response prediction was found. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 5-7, beck2014mutationofpoc1b pages 3-4)

12. Treatment and current implementation

Current real-world management is supportive, not mutation-correcting: inherited-retinal-disease assessment and molecular confirmation; visual rehabilitation and appropriate low-vision aids; refraction and management of treatable coincident ocular conditions; accommodations for photophobia; and longitudinal retinal follow-up. The article recorded cataract extraction in one older patient but did not demonstrate cataract surgery as a treatment of the underlying dystrophy. Suggested NCIT intervention concepts, requiring terminology-version verification, are Genetic Testing, Genetic Counseling, Electroretinography, Optical Coherence Tomography, Visual Rehabilitation, and Cataract Surgery when independently indicated. These are intervention annotations, not assertions of proven disease modification. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 5-7, cruz2024spectrumofvariants pages 1-2)

Disease-modifying and experimental interventions: no POC1B/CORD20-specific drug, approved gene augmentation, editing, antisense or siRNA therapy, stem-cell therapy, immune therapy, treatment-response rate, adverse-event profile, or identified POC1B-specific interventional NCT trial was established by the retrieved evidence and targeted registry searches. Wild-type POC1B mRNA partially rescued zebrafish morphants, not human vision; it is a proof-of-mechanism result, not a clinical therapy. General inherited-retinal-disease gene therapy research must not be presented as an available CORD20 treatment. No POC1B-specific pharmacogenomic dosing guideline is established. (roosing2014disruptionofthe pages 7-9, roosing2014disruptionofthe pages 1-2)

13. Prevention

There is no demonstrated lifestyle or vaccine-based primary prevention of inherited biallelic POC1B disease and no applicable immunization or antimicrobial prophylaxis. Before conception, identify familial pathogenic variants, offer genetic counseling and discuss reproductive options, including carrier testing of the partner and, when appropriate and available, prenatal testing or preimplantation genetic testing. For an affected family, cascade testing of relatives and timely ophthalmic assessment can identify at-risk individuals and support planning; this is secondary prevention of delayed diagnosis, not prevention of the genotype. Tertiary measures concern rehabilitation, visual adaptations, and management of coexisting ocular problems, without proven slowing of POC1B retinal degeneration. No CORD20 newborn or population-screening program was identified. (roosing2014disruptionofthe pages 4-5, roosing2014disruptionofthe pages 1-2)

14. Other species and naturally occurring disease

The documented disease is human (NCBI Taxon 9606). Orthologous poc1b/Poc1b has been studied experimentally in zebrafish (Danio rerio; Taxon 7955), mouse (Mus musculus; Taxon 10090), and rat (Rattus norvegicus; Taxon 10116). Rodent retinal localization and zebrafish functional defects support conservation, but a spontaneous naturally occurring veterinary cone-rod dystrophy specifically attributable to POC1B, an affected breed/VBO entry, and species-specific clinical incidence were not established by the retrieved reports. This is a noninfectious hereditary condition, so zoonotic transmission is not applicable. NCBI Gene accessions for each ortholog require independent database confirmation. (roosing2014disruptionofthe pages 5-7, zhang2015knockdownofpoc1b pages 1-5, beck2014mutationofpoc1b pages 6-8)

15. Experimental models and limitations

Zebrafish morpholino knockdown: poc1b depletion produced small eyes, reduced optokinetic responses and shortened/absent photoreceptor outer segments; in the original study, 39.8% of larvae receiving a specified 6-ng morpholino dose had small eyes. Wild-type human POC1B mRNA partially rescued ocular defects, while p.Gln67del and p.Arg106Pro constructs did not. A separate zebrafish study described disrupted photoreceptor sensory cilia and visual function. These experiments recapitulate aspects of ciliary/visual dysfunction but morpholino exposure, developmental abnormalities and small-eye frequency must not be confused with frequencies in humans with CORD20. (roosing2014disruptionofthe pages 5-7, roosing2014disruptionofthe pages 7-9, zhang2015knockdownofpoc1b pages 1-5)

Cell and comparative systems: transfected human hTERT-RPE1 cells visualized basal-body localization of normal versus mutant POC1B; HEK293T coimmunoprecipitation tested FAM161A binding; human and mouse retinal immunostaining localized native protein near photoreceptor centrioles. The 2024 POC1A–POC1B study used cellular/structural analysis to delineate the inner-centriole interaction network, adding mechanistic insight but not producing a validated patient-specific treatment. These systems cannot reproduce an affected human's full natural history. No well-characterized CORD20-specific patient iPSC-retinal organoid, mouse knock-in natural-history dataset, or gene-therapy efficacy model was identified in the retrieved primary evidence. Model-resource starting points include ZFIN, MGI, and the Alliance of Genome Resources, with allele availability requiring live verification. (roosing2014disruptionofthe pages 7-9, sala2024aninteractionnetwork pages 1-2, beck2014mutationofpoc1b pages 6-8)

Selected exact abstract quotations and evidence provenance

  • Human genetics plus in vitro/zebrafish, Roosing et al., online 10 July 2014; journal issue 7 August 2014: “Altogether, this study demonstrates that POC1B mutations result in a defect of the photoreceptor sensory cilium and thus affect cone and rod photoreceptors.” The abstract also states that mutant constructs lost basal-body localization and failed zebrafish rescue. DOI: 10.1016/j.ajhg.2014.06.012. A PMID was not present in the retrieved text; it should be verified in PubMed rather than guessed. (roosing2014disruptionofthe pages 1-2, roosing2014disruptionofthe pages 10-11)
  • Human syndromic allelic evidence plus zebrafish, Beck et al., online 16 July 2014: “The phenotype associated with homozygous p.Arg106ProPOC1B may thus be highly variable.” This cautions against equating isolated CORD20 with the renal–neurological family. DOI: 10.1002/humu.22618. PMID not verified from retrieved text. (beck2014mutationofpoc1b pages 1-2)
  • Experimental cellular/animal evidence, Zhang et al., 2015: “poc1b is required for photoreceptor sensory cilia formation and normal vision in zebrafish.” DOI: 10.1016/j.bbrc.2015.06.083. PMID not verified from retrieved text. (zhang2015knockdownofpoc1b pages 1-5)
  • Human IRD cohort, Villafuerte-de la Cruz et al., February 2024: “A total of 126 patients were included. Cases were solved in 74.6% of the study’s population.” This is all inherited retinal dystrophies, not a CORD20 diagnostic yield. DOI: 10.1186/s12886-023-03276-7. PMID not verified from retrieved text. (cruz2024spectrumofvariants pages 1-2, cruz2024spectrumofvariants pages 4-5)
  • Primary cell/structural mechanism, Sala et al., November 2024: the study's abstract describes “an interaction network organised by POC1A-POC1B heterodimers within the centriole lumen.” It contains no CORD20 patient cohort. DOI: 10.1038/s41467-024-54247-5. PMID not verified from retrieved text. (sala2024aninteractionnetwork pages 1-2)

Priority curation caveat: do not infer subtype-wide prevalence or clinical-feature percentages from four patients; do not interpret a VUS as proven pathogenic, conflate initial achromatopsia-like symptoms with a stationary course, or transfer severe syndromic renal outcomes to nonsyndromic CORD20. Exact HPO/GO/CL/UBERON/NCIT identifiers, a numerical HGNC identifier, Orphanet/ICD mappings, current ClinVar and gnomAD records, and PMIDs require live authoritative-database verification before production knowledge-base import. (roosing2014disruptionofthe pages 4-5, cruz2024spectrumofvariants pages 4-5, beck2014mutationofpoc1b pages 1-2)

References

  1. (roosing2014disruptionofthe pages 1-2): Susanne Roosing, Ideke J.C. Lamers, Erik de Vrieze, L. Ingeborgh van den Born, Stanley Lambertus, Heleen H. Arts, Theo A. Peters, Carel B. Hoyng, Hannie Kremer, Lisette Hetterschijt, Stef J.F. Letteboer, Erwin van Wijk, Ronald Roepman, Anneke I. den Hollander, Frans P.M. Cremers, Karsten Boldt, Elfride de Baere, Caroline C.W. Klaver, Frauke Coppieters, David A. Koolen, Dorien Lugtenberg, Kornelia Neveling, Jeroen van Reeuwijk, Marius Ueffing, Sylvia E.C. van Beersum, and Marijke N. Zonneveld-Vrieling. Disruption of the basal body protein poc1b results in autosomal-recessive cone-rod dystrophy. American Journal of Human Genetics, 95:131-142, Aug 2014. URL: https://doi.org/10.1016/j.ajhg.2014.06.012, doi:10.1016/j.ajhg.2014.06.012. This article has 89 citations and is from a highest quality peer-reviewed journal.

  2. (roosing2014disruptionofthe pages 4-5): Susanne Roosing, Ideke J.C. Lamers, Erik de Vrieze, L. Ingeborgh van den Born, Stanley Lambertus, Heleen H. Arts, Theo A. Peters, Carel B. Hoyng, Hannie Kremer, Lisette Hetterschijt, Stef J.F. Letteboer, Erwin van Wijk, Ronald Roepman, Anneke I. den Hollander, Frans P.M. Cremers, Karsten Boldt, Elfride de Baere, Caroline C.W. Klaver, Frauke Coppieters, David A. Koolen, Dorien Lugtenberg, Kornelia Neveling, Jeroen van Reeuwijk, Marius Ueffing, Sylvia E.C. van Beersum, and Marijke N. Zonneveld-Vrieling. Disruption of the basal body protein poc1b results in autosomal-recessive cone-rod dystrophy. American Journal of Human Genetics, 95:131-142, Aug 2014. URL: https://doi.org/10.1016/j.ajhg.2014.06.012, doi:10.1016/j.ajhg.2014.06.012. This article has 89 citations and is from a highest quality peer-reviewed journal.

  3. (beck2014mutationofpoc1b pages 1-2): Bodo B. Beck, Jennifer B. Phillips, Malte P. Bartram, Jeremy Wegner, Michaela Thoenes, Andrea Pannes, Josephina Sampson, Raoul Heller, Heike Göbel, Friederike Koerber, Antje Neugebauer, Andrea Hedergott, Gudrun Nürnberg, Peter Nürnberg, Holger Thiele, Janine Altmüller, Mohammad R. Toliat, Simon Staubach, Kym M. Boycott, Enza Maria Valente, Andreas R. Janecke, Tobias Eisenberger, Carsten Bergmann, Lars Tebbe, Yang Wang, Yundong Wu, Andrew M. Fry, Monte Westerfield, Uwe Wolfrum, and Hanno J. Bolz. Mutation of poc1b in a severe syndromic retinal ciliopathy. Human Mutation, 35:1153-1162, Oct 2014. URL: https://doi.org/10.1002/humu.22618, doi:10.1002/humu.22618. This article has 77 citations and is from a domain leading peer-reviewed journal.

  4. (roosing2014disruptionofthe pages 5-7): Susanne Roosing, Ideke J.C. Lamers, Erik de Vrieze, L. Ingeborgh van den Born, Stanley Lambertus, Heleen H. Arts, Theo A. Peters, Carel B. Hoyng, Hannie Kremer, Lisette Hetterschijt, Stef J.F. Letteboer, Erwin van Wijk, Ronald Roepman, Anneke I. den Hollander, Frans P.M. Cremers, Karsten Boldt, Elfride de Baere, Caroline C.W. Klaver, Frauke Coppieters, David A. Koolen, Dorien Lugtenberg, Kornelia Neveling, Jeroen van Reeuwijk, Marius Ueffing, Sylvia E.C. van Beersum, and Marijke N. Zonneveld-Vrieling. Disruption of the basal body protein poc1b results in autosomal-recessive cone-rod dystrophy. American Journal of Human Genetics, 95:131-142, Aug 2014. URL: https://doi.org/10.1016/j.ajhg.2014.06.012, doi:10.1016/j.ajhg.2014.06.012. This article has 89 citations and is from a highest quality peer-reviewed journal.

  5. (roosing2014disruptionofthe pages 10-11): Susanne Roosing, Ideke J.C. Lamers, Erik de Vrieze, L. Ingeborgh van den Born, Stanley Lambertus, Heleen H. Arts, Theo A. Peters, Carel B. Hoyng, Hannie Kremer, Lisette Hetterschijt, Stef J.F. Letteboer, Erwin van Wijk, Ronald Roepman, Anneke I. den Hollander, Frans P.M. Cremers, Karsten Boldt, Elfride de Baere, Caroline C.W. Klaver, Frauke Coppieters, David A. Koolen, Dorien Lugtenberg, Kornelia Neveling, Jeroen van Reeuwijk, Marius Ueffing, Sylvia E.C. van Beersum, and Marijke N. Zonneveld-Vrieling. Disruption of the basal body protein poc1b results in autosomal-recessive cone-rod dystrophy. American Journal of Human Genetics, 95:131-142, Aug 2014. URL: https://doi.org/10.1016/j.ajhg.2014.06.012, doi:10.1016/j.ajhg.2014.06.012. This article has 89 citations and is from a highest quality peer-reviewed journal.

  6. (roosing2014disruptionofthe pages 7-9): Susanne Roosing, Ideke J.C. Lamers, Erik de Vrieze, L. Ingeborgh van den Born, Stanley Lambertus, Heleen H. Arts, Theo A. Peters, Carel B. Hoyng, Hannie Kremer, Lisette Hetterschijt, Stef J.F. Letteboer, Erwin van Wijk, Ronald Roepman, Anneke I. den Hollander, Frans P.M. Cremers, Karsten Boldt, Elfride de Baere, Caroline C.W. Klaver, Frauke Coppieters, David A. Koolen, Dorien Lugtenberg, Kornelia Neveling, Jeroen van Reeuwijk, Marius Ueffing, Sylvia E.C. van Beersum, and Marijke N. Zonneveld-Vrieling. Disruption of the basal body protein poc1b results in autosomal-recessive cone-rod dystrophy. American Journal of Human Genetics, 95:131-142, Aug 2014. URL: https://doi.org/10.1016/j.ajhg.2014.06.012, doi:10.1016/j.ajhg.2014.06.012. This article has 89 citations and is from a highest quality peer-reviewed journal.

  7. (roosing2014disruptionofthe media 421751db): Susanne Roosing, Ideke J.C. Lamers, Erik de Vrieze, L. Ingeborgh van den Born, Stanley Lambertus, Heleen H. Arts, Theo A. Peters, Carel B. Hoyng, Hannie Kremer, Lisette Hetterschijt, Stef J.F. Letteboer, Erwin van Wijk, Ronald Roepman, Anneke I. den Hollander, Frans P.M. Cremers, Karsten Boldt, Elfride de Baere, Caroline C.W. Klaver, Frauke Coppieters, David A. Koolen, Dorien Lugtenberg, Kornelia Neveling, Jeroen van Reeuwijk, Marius Ueffing, Sylvia E.C. van Beersum, and Marijke N. Zonneveld-Vrieling. Disruption of the basal body protein poc1b results in autosomal-recessive cone-rod dystrophy. American Journal of Human Genetics, 95:131-142, Aug 2014. URL: https://doi.org/10.1016/j.ajhg.2014.06.012, doi:10.1016/j.ajhg.2014.06.012. This article has 89 citations and is from a highest quality peer-reviewed journal.

  8. (beck2014mutationofpoc1b pages 3-4): Bodo B. Beck, Jennifer B. Phillips, Malte P. Bartram, Jeremy Wegner, Michaela Thoenes, Andrea Pannes, Josephina Sampson, Raoul Heller, Heike Göbel, Friederike Koerber, Antje Neugebauer, Andrea Hedergott, Gudrun Nürnberg, Peter Nürnberg, Holger Thiele, Janine Altmüller, Mohammad R. Toliat, Simon Staubach, Kym M. Boycott, Enza Maria Valente, Andreas R. Janecke, Tobias Eisenberger, Carsten Bergmann, Lars Tebbe, Yang Wang, Yundong Wu, Andrew M. Fry, Monte Westerfield, Uwe Wolfrum, and Hanno J. Bolz. Mutation of poc1b in a severe syndromic retinal ciliopathy. Human Mutation, 35:1153-1162, Oct 2014. URL: https://doi.org/10.1002/humu.22618, doi:10.1002/humu.22618. This article has 77 citations and is from a domain leading peer-reviewed journal.

  9. (cruz2024spectrumofvariants pages 4-5): Rocio A. Villafuerte-de la Cruz, Lucas A. Garza-Garza, Manuel Garza-Leon, Cesar Rodriguez-De la Torre, Cinthya Parra-Bernal, Ilse Vazquez-Camas, David Ramos-Gonzalez, Andrea Rangel-Padilla, Angelina Espino Barros-Palau, Jose Nava-García, Javier Castillo-Velazquez, Erick Castillo-De Leon, Agustin Del Valle-Penella, Jorge E. Valdez-Garcia, and Augusto Rojas-Martinez. Spectrum of variants associated with inherited retinal dystrophies in northeast mexico. BMC Ophthalmology, Feb 2024. URL: https://doi.org/10.1186/s12886-023-03276-7, doi:10.1186/s12886-023-03276-7. This article has 9 citations and is from a peer-reviewed journal.

  10. (cruz2024spectrumofvariants pages 2-4): Rocio A. Villafuerte-de la Cruz, Lucas A. Garza-Garza, Manuel Garza-Leon, Cesar Rodriguez-De la Torre, Cinthya Parra-Bernal, Ilse Vazquez-Camas, David Ramos-Gonzalez, Andrea Rangel-Padilla, Angelina Espino Barros-Palau, Jose Nava-García, Javier Castillo-Velazquez, Erick Castillo-De Leon, Agustin Del Valle-Penella, Jorge E. Valdez-Garcia, and Augusto Rojas-Martinez. Spectrum of variants associated with inherited retinal dystrophies in northeast mexico. BMC Ophthalmology, Feb 2024. URL: https://doi.org/10.1186/s12886-023-03276-7, doi:10.1186/s12886-023-03276-7. This article has 9 citations and is from a peer-reviewed journal.

  11. (cruz2024spectrumofvariants pages 1-2): Rocio A. Villafuerte-de la Cruz, Lucas A. Garza-Garza, Manuel Garza-Leon, Cesar Rodriguez-De la Torre, Cinthya Parra-Bernal, Ilse Vazquez-Camas, David Ramos-Gonzalez, Andrea Rangel-Padilla, Angelina Espino Barros-Palau, Jose Nava-García, Javier Castillo-Velazquez, Erick Castillo-De Leon, Agustin Del Valle-Penella, Jorge E. Valdez-Garcia, and Augusto Rojas-Martinez. Spectrum of variants associated with inherited retinal dystrophies in northeast mexico. BMC Ophthalmology, Feb 2024. URL: https://doi.org/10.1186/s12886-023-03276-7, doi:10.1186/s12886-023-03276-7. This article has 9 citations and is from a peer-reviewed journal.

  12. (sala2024aninteractionnetwork pages 1-2): Cornelia Sala, Martin Würtz, Enrico Salvatore Atorino, Annett Neuner, Patrick Partscht, Thomas Hoffmann, Sebastian Eustermann, and Elmar Schiebel. An interaction network of inner centriole proteins organised by poc1a-poc1b heterodimer crosslinks ensures centriolar integrity. Nature Communications, Nov 2024. URL: https://doi.org/10.1038/s41467-024-54247-5, doi:10.1038/s41467-024-54247-5. This article has 22 citations and is from a highest quality peer-reviewed journal.

  13. (beck2014mutationofpoc1b pages 6-8): Bodo B. Beck, Jennifer B. Phillips, Malte P. Bartram, Jeremy Wegner, Michaela Thoenes, Andrea Pannes, Josephina Sampson, Raoul Heller, Heike Göbel, Friederike Koerber, Antje Neugebauer, Andrea Hedergott, Gudrun Nürnberg, Peter Nürnberg, Holger Thiele, Janine Altmüller, Mohammad R. Toliat, Simon Staubach, Kym M. Boycott, Enza Maria Valente, Andreas R. Janecke, Tobias Eisenberger, Carsten Bergmann, Lars Tebbe, Yang Wang, Yundong Wu, Andrew M. Fry, Monte Westerfield, Uwe Wolfrum, and Hanno J. Bolz. Mutation of poc1b in a severe syndromic retinal ciliopathy. Human Mutation, 35:1153-1162, Oct 2014. URL: https://doi.org/10.1002/humu.22618, doi:10.1002/humu.22618. This article has 77 citations and is from a domain leading peer-reviewed journal.

  14. (zhang2015knockdownofpoc1b pages 1-5): Conghui Zhang, Qi Zhang, Fang Wang, and Qin Liu. Knockdown of poc1b causes abnormal photoreceptor sensory cilium and vision impairment in zebrafish. Biochemical and biophysical research communications, 465 4:651-7, Oct 2015. URL: https://doi.org/10.1016/j.bbrc.2015.06.083, doi:10.1016/j.bbrc.2015.06.083. This article has 16 citations and is from a peer-reviewed journal.

  15. (sala2024aninteractionnetwork pages 9-10): Cornelia Sala, Martin Würtz, Enrico Salvatore Atorino, Annett Neuner, Patrick Partscht, Thomas Hoffmann, Sebastian Eustermann, and Elmar Schiebel. An interaction network of inner centriole proteins organised by poc1a-poc1b heterodimer crosslinks ensures centriolar integrity. Nature Communications, Nov 2024. URL: https://doi.org/10.1038/s41467-024-54247-5, doi:10.1038/s41467-024-54247-5. This article has 22 citations and is from a highest quality peer-reviewed journal.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.3.0.

Outcome Count
References checked 5
Resolved 5
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 5
On topic 1
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 4
Resolved 4
Unresolved (possible confabulation) 0
Obsolete 0
Unverifiable 0
Terms whose name was checked 1
Terms named correctly 0
Terms named as a different term 1

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • MONDO:0014427 (2 mentions) - the report calls it "if available"; MONDO calls it cone-rod dystrophy 20